Publications

1. Borgmästars E, Jacobson S, Simm M, Johansson M, Billing O, Lundin C, et al. (2024). Metabolomics for early pancreatic cancer detection in plasma samples from a Swedish prospective population-based biobank. J Gastrointest Oncol. 15(2):755–67. https://doi.org/10.21037/jgo-23-930 PMID:38756646
2. Bouras E, Gill D, Zuber V, Murphy N, Dimou N, Aleksandrova K, et al. (2024). Identification of potential mediators of the relationship between body mass index and colorectal cancer: a Mendelian randomization analysis. Int J Epidemiol. 53(3):dyae067. https://doi.org/10.1093/ije/dyae067 PMID:38725300
3. Bull CJ, Hazelwood E, Legge DN, Corbin LJ, Richardson TG, Lee M, et al. (2024). Impact of weight loss on cancer-related proteins in serum: results from a cluster randomised controlled trial of individuals with type 2 diabetes. EBioMedicine. 100:104977. https://doi.org/10.1016/j.ebiom.2024.104977 PMID:38290287
4. Caramenti L, Gradowska PL, Moriña D, Byrnes G, Cardis E, Hauptmann M (2024). Finite-Sample Bias of the Linear Excess Relative Risk in Cohort Studies of Computed Tomography-Related Radiation Exposure and Cancer. Radiat Res. 201(3):206–14. https://doi.org/10.1667/RADE-23-00187.1 PMID:38323646
5. Cornish N, Haycock P, Brenner H, Figueiredo JC, Galesloot TE, Grant RC, et al.; InterLymph Consortium, INVENT-MVP Consortium (2024). Causal relationships between risk of venous thromboembolism and 18 cancers: a bidirectional Mendelian randomization analysis. Int J Epidemiol. 53(1):11. https://doi.org/10.1093/ije/dyad170 PMID:38124529
6. Cruz-Romero SD, González S, Juez JY, Becerra DS, Baldión AM, Hakim JA, et al. (2024). TIROSEC: Molecular, Clinical and Histopathological Profile of Papillary Thyroid Carcinoma in a Colombian Cohort. Adv Ther. 41(2):792–805. https://doi.org/10.1007/s12325-023-02756-y PMID:38170436
7. Du M, Xin J, Zheng R, Yuan Q, Wang Z, Liu H, et al. (2024). CYP2A6 Activity and Cigarette Consumption Interact in Smoking-Related Lung Cancer Susceptibility. Cancer Res. 84(4):616–25. https://doi.org/10.1158/0008-5472.CAN-23-0900 PMID:38117513
8. Dunlop KLA, Singh N, Robbins HA, Zahed H, Johansson M, Rankin NM, et al. (2024). Implementation considerations for risk-tailored cancer screening in the population: A scoping review. Prev Med. 181:107897. https://doi.org/10.1016/j.ypmed.2024.107897 PMID:38378124
9. Engels EA, Shiels MS, Barnabas RV, Bohlius J, Brennan P, Castilho J, et al. (2024). State of the science and future directions for research on HIV and cancer: Summary of a joint workshop sponsored by IARC and NCI. Int J Cancer. 154(4):596–606. https://doi.org/10.1002/ijc.34727 PMID:37715370
10. Etemadi A, Poustchi H, Chang CM, Calafat AM, Blount BC, Bhandari D, et al. (2024). Exposure to polycyclic aromatic hydrocarbons, volatile organic compounds, and tobacco-specific nitrosamines and incidence of esophageal cancer. J Natl Cancer Inst. 116(3):379–88. https://doi.org/10.1093/jnci/djad218 PMID:37856326
11. Grassmann F, Mälarstig A, Dahl L, Bendes A, Dale M, Thomas CE, et al. (2024). The impact of circulating protein levels identified by affinity proteomics on short-term, overall breast cancer risk. Br J Cancer. 130(4):620–7. https://doi.org/10.1038/s41416-023-02541-2 PMID:38135714
12. Gustafsson S, Lampa E, Eriksson KJ, Butterworth AS, Elmståhl S, Engström G, et al. (2024). Markers of imminent myocardial infarction. Nat Cardiovasc Res. 3(2):130–9. https://doi.org/10.1038/s44161-024-00422-2
13. Johansson M, Robbins HA (2024). Harnessing population-wide health data to predict cancer risk. Lancet Digit Health. 6(6):e377–8. https://doi.org/10.1016/S2589-7500(24)00093-1 PMID:38789137
14. Koyanagi YN, Nakatochi M, Namba S, Oze I, Charvat H, Narita A, et al.; BioBank Japan Project (2024). Genetic architecture of alcohol consumption identified by a genotype-stratified GWAS and impact on esophageal cancer risk in Japanese people. Sci Adv. 10(4):eade2780. https://doi.org/10.1126/sciadv.ade2780 PMID:38277453
15. Kusters JMA, Diergaarde B, Ness A, Schim van der Loeff MF, Heijne JCM, Schroeder L, et al. (2024). Diagnostic accuracy of HPV16 early antigen serology for HPV-driven oropharyngeal cancer is independent of age and sex. Int J Cancer. 154(2):389–402. https://doi.org/10.1002/ijc.34710 PMID:37694289
16. Lam S, Bai C, Baldwin DR, Chen Y, Connolly C, de Koning H, et al. (2024). Current and Future Perspectives on Computed Tomography Screening for Lung Cancer: A Roadmap From 2023 to 2027 From the International Association for the Study of Lung Cancer. J Thorac Oncol. 19(1):36–51. https://doi.org/10.1016/j.jtho.2023.07.019 PMID:37487906
17. Li Y, Xiao X, Li J, Han Y, Cheng C, Fernandes GF, et al. (2024). Lung Cancer in Ever- and Never-Smokers: Findings from Multi-Population GWAS Studies. Cancer Epidemiol Biomarkers Prev. 33(3):389–99. https://doi.org/10.1158/1055-9965.EPI-23-0613 PMID:38180474
18. Matos LL, Kowalski LP, Chaves ALF, de Oliveira TB, Marta GN, Curado MP, et al.; HEADSpAcE Consortium (2024). Latin American Consensus on the Treatment of Head and Neck Cancer. JCO Glob Oncol. 10(10):e2300343. https://doi.org/10.1200/GO.23.00343 PMID:38603656
19. Morales-Berstein F, Biessy C, Viallon V, Goncalves-Soares A, Casagrande C, Hémon B, et al.; EPIC Network (2024). Ultra-processed foods, adiposity and risk of head and neck cancer and oesophageal adenocarcinoma in the European Prospective Investigation into Cancer and Nutrition study: a mediation analysis. Eur J Nutr. 63(2):377–96. https://doi.org/10.1007/s00394-023-03270-1 PMID:37989797
20. Perdomo S, Abedi-Ardekani B, de Carvalho AC, Ferreiro-Iglesias A, Gaborieau V, Cattiaux T, et al. (2024). The Mutographs biorepository: A unique genomic resource to study cancer around the world. Cell Genom. 4(3):100500. https://doi.org/10.1016/j.xgen.2024.100500 PMID:38325367
21. Purdue MP, Dutta D, Machiela MJ, Gorman BR, Winter T, Okuhara D, et al.; BioBank Japan Project; FinnGen (2024). Multi-ancestry genome-wide association study of kidney cancer identifies 63 susceptibility regions. Nat Genet. 56(5):809–18. https://doi.org/10.1038/s41588-024-01725-7 PMID:38671320
22. Senkin S, Moody S, Díaz-Gay M, Abedi-Ardekani B, Cattiaux T, Ferreiro-Iglesias A, et al. (2024). Geographic variation of mutagenic exposures in kidney cancer genomes. Nature. 629(8013):910–8. https://doi.org/10.1038/s41586-024-07368-2 PMID:38693263
23. Yang JJ, Wen W, Zahed H, Zheng W, Lan Q, Abe SK, et al. (2024). Lung Cancer Risk Prediction Models for Asian Ever-Smokers. J Thorac Oncol. 19(3):451–64. https://doi.org/10.1016/j.jtho.2023.11.002 PMID:37944700
24. Yano Y, Abnet CC, Roshandel G, Graf A, Poustchi H, Khoshnia M, et al. (2024). Dental health and lung cancer risk in the Golestan Cohort Study. BMC Cancer. 24(1):74. https://doi.org/10.1186/s12885-024-11850-5 PMID:38218793
25. Yarmolinsky J, Robinson JW, Mariosa D, Karhunen V, Huang J, Dimou N, et al.; International Lung Cancer Consortium; PRACTICAL Consortium (2024). Association between circulating inflammatory markers and adult cancer risk: a Mendelian randomization analysis. EBioMedicine. 100:104991. https://doi.org/10.1016/j.ebiom.2024.104991 PMID:38301482
26. Yarmolinsky J, Robinson JW, Mariosa D, Karhunen V, Huang J, Dimou N, et al.; International Lung Cancer Consortium; PRACTICAL Consortium (2024). Association between circulating inflammatory markers and adult cancer risk: a Mendelian randomization analysis. EBioMedicine. 100:104991. https://doi.org/10.1016/j.ebiom.2024.104991 PMID:38301482
27. Yazdanpanah MH, Sharafkhah M, Poustchi H, Etemadi A, Sheikh M, Kamangar F, et al. (2024). Mineral Intake and Cardiovascular Disease, Cancer, and All-Cause Mortality: Findings from the Golestan Cohort Study. Nutrients. 16(3):23. https://doi.org/10.3390/nu16030344 PMID:38337629
28. Zahed H, Feng X, Sheikh M, Bray F, Ferlay J, Ginsburg O, et al. (2024). Age at diagnosis for lung, colon, breast and prostate cancers: An international comparative study. Int J Cancer. 154(1):28–40. https://doi.org/10.1002/ijc.34671 PMID:37615573
29. Zhao X, Yang M, Fan J, Wang M, Wang Y, Qin N, et al. (2024). Identification of genetically predicted DNA methylation markers associated with non-small cell lung cancer risk among 34,964 cases and 448,579 controls. Cancer. 130(6):913–26. https://doi.org/10.1002/cncr.35130 PMID:38055287
30. Albanes D, Alcala K, Alcala N, Amos CI, Arslan AA, Bassett JK, et al.; Lung Cancer Cohort Consortium (LC3) (2023). The blood proteome of imminent lung cancer diagnosis. Nat Commun. 14(1):3042. https://doi.org/10.1038/s41467-023-37979-8 PMID:37264016
31. Alcala K, Poustchi H, Viallon V, Islami F, Pourshams A, Sadjadi A, et al. (2023). Incident cancers attributable to using opium and smoking cigarettes in the Golestan cohort study. EClinicalMedicine. 64:102229. https://doi.org/10.1016/j.eclinm.2023.102229 PMID:37781157
32. Alcala K, Zahed H, Cortez Cardoso Penha R, Alcala N, Robbins HA, Smith-Byrne K, et al. (2023). Kidney Function and Risk of Renal Cell Carcinoma. Cancer Epidemiol Biomarkers Prev. 32(11):1644–50. https://doi.org/10.1158/1055-9965.EPI-23-0558 PMID:37668600
33. Alcala N, Fernandez-Cuesta LA (2023). Lifting the curtain on molecular differences between malignant pleural mesotheliomas. Nat Genet. 55(4):540–1. https://doi.org/10.1038/s41588-023-01322-0 PMID:36928604
34. Alcala N, Voegele C, Mangiante L, Sexton-Oates A, Clevers H, Fernandez-Cuesta L, et al. (2024). Multi-omic dataset of patient-derived tumor organoids of neuroendocrine neoplasms. Gigascience. 13:13. https://doi.org/10.1093/gigascience/giae008 PMID:38451475
35. Arboleda LPA, de Carvalho GB, Santos-Silva AR, Fernandes GA, Vartanian JG, Conway DI, et al. (2023). Squamous Cell Carcinoma of the Oral Cavity, Oropharynx, and Larynx: A Scoping Review of Treatment Guidelines Worldwide. Cancers (Basel). 15(17):4405. https://doi.org/10.3390/cancers15174405 PMID:37686681
36. Arboleda LPA, Neves AB, Kohler HF, Vartanian JG, Candelária LM, Borges MF, et al. (2023). Overview of glottic laryngeal cancer treatment recommendation changes in the NCCN guidelines from 2011 to 2022. Cancer Rep (Hoboken). 6(8):e1837. https://doi.org/10.1002/cnr2.1837 PMID:37288471
37. Berndt SI, Vijai J, Benavente Y, Camp NJ, Nieters A, Wang Z, et al. (2023). Correction: Distinct germline genetic susceptibility profiles identified for common non-Hodgkin lymphoma subtypes. Leukemia. 37(10):2142–2142. https://doi.org/10.1038/s41375-023-01978-x PMID:37666943
38. Blázquez-Encinas R, García-Vioque V, Caro-Cuenca T, Moreno-Montilla MT, Mangili F, Alors-Pérez E, et al. (2023). Altered splicing machinery in lung carcinoids unveils NOVA1, PRPF8 and SRSF10 as novel candidates to understand tumor biology and expand biomarker discovery. J Transl Med. 21(1):879. https://doi.org/10.1186/s12967-023-04754-8 PMID:38049848
39. Budhathoki S, Diergaarde B, Liu G, Olshan A, Ness A, Waterboer T, et al. (2023). A risk prediction model for head and neck cancers incorporating lifestyle factors, HPV serology and genetic markers. Int J Cancer. 152(10):2069–80. https://doi.org/10.1002/ijc.34444 PMID:36694401
40. Callister MEJ, Crosbie EJ, Crosbie PAJ, Robbins HA (2023). Evaluating multi-cancer early detection tests: an argument for the outcome of recurrence-updated stage. Br J Cancer. 129(8):1209–11. https://doi.org/10.1038/s41416-023-02434-4 PMID:37726480
41. Casolino R, Johns AL, Courtot M, Lawlor RT, De Lorenzo F, Horgan D, et al.; Lancet Oncology Commission on Cancer Omics and Precision Oncology (2023). Accelerating cancer omics and precision oncology in health care and research: a Lancet Oncology Commission. Lancet Oncol. 24(2):123–5. https://doi.org/10.1016/S1470-2045(23)00007-4
42. Cheng C, Hong W, Li Y, Xiao X, McKay J, Han Y, et al.; INTEGRAL-ILCCO Lung Cancer Consortium (2023). Mosaic Chromosomal Alterations Are Associated With Increased Lung Cancer Risk: Insight From the INTEGRAL-ILCCO Cohort Analysis. J Thorac Oncol. 18(8):1003–16. https://doi.org/10.1016/j.jtho.2023.05.001 PMID:37150255
43. Clasen JL, Mabunda R, Heath AK, Kaaks R, Katzke V, Schulze MB, et al. (2023). Reproductive and hormonal factors and risk of renal cell carcinoma among women in the European Prospective Investigation into Cancer and Nutrition. Cancer Med. 12(14):15588–600. https://doi.org/10.1002/cam4.6207 PMID:37269199
44. Cortez Cardoso Penha R, Smith-Byrne K, Atkins JR, Haycock PC, Kar S, Codd V, et al. (2023). Common genetic variations in telomere length genes and lung cancer: a Mendelian randomisation study and its novel application in lung tumour transcriptome. Elife. 12:12. PMID:37079368
45. D’Souza G, Tewari SR, Troy T, Waterboer T, Struijk L, Castillo R, et al. (2023). Prevalence of oral and blood oncogenic human papillomavirus biomarkers among an enriched screening population: Baseline results of the MOUTH study. Cancer. 129(15):2373–84. https://doi.org/10.1002/cncr.34783 PMID:37032449
46. Dayton TL, Alcala N, Moonen L, den Hartigh L, Geurts V, Mangiante L, et al. (2023). Druggable growth dependencies and tumor evolution analysis in patient-derived organoids of neuroendocrine neoplasms from multiple body sites. Cancer Cell. 41(12):2083–2099.e9. https://doi.org/10.1016/j.ccell.2023.11.007 PMID:38086335
47. Díaz-Gay M, Vangara R, Barnes M, Wang X, Islam SMA, Vermes I, et al. (2023). Assigning mutational signatures to individual samples and individual somatic mutations with SigProfilerAssignment. Bioinformatics. 39(12):5. https://doi.org/10.1093/bioinformatics/btad756 PMID:38096571
48. Díaz-Velásquez CE, Gitler R, Antoniano A, Kershenovich Sefchovich R, De La Cruz-Montoya AH, Martínez-Gregorio H, et al. (2023). Evaluation of genetic alterations in hereditary cancer susceptibility genes in the Ashkenazi Jewish women community of Mexico. Front Genet. 14:1094260. https://doi.org/10.3389/fgene.2023.1094260 PMID:36845387
49. Dumontet C, Demangel D, Galia P, Karlin L, Roche L, Fauvernier M, et al. (2023). Clinical characteristics and outcome of 318 families with familial monoclonal gammopathy: A multicenter Intergroupe Francophone du Myélome study. Am J Hematol. 98(2):264–71. https://doi.org/10.1002/ajh.26785 PMID:36588407
50. Fares AF, Li Y, Jiang M, Brown MC, Lam ACL, Aggarwal R, et al. (2023). Association between duration of smoking abstinence before non-small-cell lung cancer diagnosis and survival: a retrospective, pooled analysis of cohort studies. Lancet Public Health. 8(9):e691–700. https://doi.org/10.1016/S2468-2667(23)00131-7 PMID:37633678
51. Feng X, Muller DC, Zahed H, Alcala K, Guida F, Smith-Byrne K, et al. (2023). Evaluation of pre-diagnostic blood protein measurements for predicting survival after lung cancer diagnosis. EBioMedicine. 92:104623. https://doi.org/10.1016/j.ebiom.2023.104623 PMID:37236058
52. Feng X, Wu WY, Onwuka JU, Haider Z, Alcala K, Smith-Byrne K, et al. (2023). Lung cancer risk discrimination of prediagnostic proteomics measurements compared with existing prediction tools. J Natl Cancer Inst. 115(9):1050–9. https://doi.org/10.1093/jnci/djad071 PMID:37260165
53. Fernandez-Cuesta L, Sexton-Oates A, Bayat L, Foll M, Lau SCM, Leal T (2023). Spotlight on Small-Cell Lung Cancer and Other Lung Neuroendocrine Neoplasms. Am Soc Clin Oncol Educ Book. 43(43):e390794. https://doi.org/10.1200/EDBK_390794 PMID:37229617
54. García-Pardo M, Chang A, Schmid S, Dong M, Brown MC, Christiani D, et al. (2023). Respiratory and Cardiometabolic Comorbidities and Stages I to III NSCLC Survival: A Pooled Analysis From the International Lung Cancer Consortium. J Thorac Oncol. 18(3):313–23. https://doi.org/10.1016/j.jtho.2022.10.020 PMID:36396063
55. Goyal N, Hennessy M, Lehman E, Lin W, Agudo A, Ahrens W, et al. (2023). Risk factors for head and neck cancer in more and less developed countries: Analysis from the INHANCE consortium. Oral Dis. 29(4):1565–78. https://doi.org/10.1111/odi.14196 PMID:35322907
56. Hadji M, Marzban M, Rashidian H, Naghibzadeh-Tahami A, Gholipour M, Mohebbi E, et al. (2023). Opium use and risk of colorectal cancer: a multi-center case-referent study in Iran. Acta Oncol. 62(12):1661–8. https://doi.org/10.1080/0284186X.2023.2276326 PMID:37934078
57. Haycock PC, Borges MC, Burrows K, Lemaitre RN, Harrison S, Burgess S, et al.; Fatty Acids in Cancer Mendelian Randomization Collaboration (2023). Design and quality control of large-scale two-sample Mendelian randomization studies. Int J Epidemiol. 52(5):1498–521. https://doi.org/10.1093/ije/dyad018 PMID:38587501
58. Hosseini E, Mokhtari Z, Poustchi H, Khoshnia M, Dawsey SM, Boffetta P, et al. (2023). Dietary Advanced Glycation End Products and Risk of Overall and Cause-Specific Mortality: Results from the Golestan Cohort Study. Int J Environ Res Public Health. 20(5):3788. https://doi.org/10.3390/ijerph20053788 PMID:36900799
59. Khan SM, Das T, Chakraborty S, Choudhury AMAR, Karim HF, Mostofa MA, et al. (2023). A transcriptome study of p53-pathway related prognostic gene signature set in bladder cancer. Heliyon. 9(10):e21058. https://doi.org/10.1016/j.heliyon.2023.e21058 PMID:37876438
60. Khodayari Moez E, Warkentin MT, Brhane Y, Lam S, Field JK, Liu G, et al. (2023). Circulating proteome for pulmonary nodule malignancy. J Natl Cancer Inst. 115(9):1060–70. https://doi.org/10.1093/jnci/djad122 PMID:37369027
61. King SD, Veliginti S, Brouwers MCGJ, Ren Z, Zheng W, Setiawan VW, et al. (2023). Genetic Susceptibility to Nonalcoholic Fatty Liver Disease and Risk for Pancreatic Cancer: Mendelian Randomization. Cancer Epidemiol Biomarkers Prev. 32(9):1265–9. https://doi.org/10.1158/1055-9965.EPI-23-0453 PMID:37351909
62. Kolijn PM, Späth F, Khouja M, Hengeveld PJ, van der Straten L, Darzentas N, et al. (2023). Genetic drivers in the natural history of chronic lymphocytic leukemia development as early as 16 years before diagnosis. Blood. 142(16):1399–403. https://doi.org/10.1182/blood.2023019609 PMID:37523714
63. Koutros S, Kiemeney LA, Pal Choudhury P, Milne RL, Lopez de Maturana E, Ye Y, et al.; UROMOL Consortium (2023). Genome-wide Association Study of Bladder Cancer Reveals New Biological and Translational Insights. Eur Urol. 84(1):127–37. https://doi.org/10.1016/j.eururo.2023.04.020 PMID:37210288
64. Landy R, Gomez I, Caverly TJ, Kawamoto K, Rivera MP, Robbins HA, et al. (2023). Methods for Using Race and Ethnicity in Prediction Models for Lung Cancer Screening Eligibility. JAMA Netw Open. 6(9):e2331155. https://doi.org/10.1001/jamanetworkopen.2023.31155 PMID:37721755
65. Landy R, Wang VL, Baldwin DR, Pinsky PF, Cheung LC, Castle PE, et al. (2023). Recalibration of a Deep Learning Model for Low-Dose Computed Tomographic Images to Inform Lung Cancer Screening Intervals. JAMA Netw Open. 6(3):e233273. https://doi.org/10.1001/jamanetworkopen.2023.3273 PMID:36929398
66. Lawrence P, Chabane M, Abrouk L, Thiesson A, Berthé D, Diarra AB, et al. (2023). First Molecular Characterization of Chronic Hepatitis B Carriers in Timbuktu, Mali. Diagnostics (Basel). 13(3):375. https://doi.org/10.3390/diagnostics13030375 PMID:36766478
67. Lee R, Robbins HA (2023). PATHFINDER: another step on the uncharted path to multicancer screening. Lancet. 402(10409):1213–5. https://doi.org/10.1016/S0140-6736(23)02050-0 PMID:37805199
68. Leyden GM, Greenwood MP, Gaborieau V, Han Y, Amos CI, Brennan P, et al. (2023). Disentangling the aetiological pathways between body mass index and site-specific cancer risk using tissue-partitioned Mendelian randomisation. Br J Cancer. 128(4):618–25. https://doi.org/10.1038/s41416-022-02060-6 PMID:36434155
69. Li M, Park JY, Sheikh M, Kayamba V, Rumgay H, Jenab M, et al. (2023). Population-based investigation of common and deviating patterns of gastric cancer and oesophageal cancer incidence across populations and time. Gut. 72(5):846–54. https://doi.org/10.1136/gutjnl-2022-328233 PMID:36241389
70. Lindström S, Wang L, Feng H, Majumdar A, Huo S, Macdonald J, et al.; Breast Cancer Association Consortium (BCAC); Colorectal Transdisciplinary Study (CORECT), Colon Cancer Family Registry Study (CCFR), Genetics And Epidemiology Of Colorectal Cancer Consortium (GECCO); Endometrial Cancer Association Consortium (ECAC); International Lung Cancer Consortium (ILCCO); Ovarian Cancer Association Consortium (OCAC); Pancreatic Cancer Cohort Consortium (Panscan); Pancreatic Cancer Case-Control Consortium (Panc4), The PRACTICAL Consortium (2023). Genome-wide analyses characterize shared heritability among cancers and identify novel cancer susceptibility regions. J Natl Cancer Inst. 115(6):712–32. https://doi.org/10.1093/jnci/djad043 PMID:36929942
71. Löding S, Andersson U, Kaaks R, Schulze MB, Pala V, Urbarova I, et al. (2023). Altered plasma metabolite levels can be detected years before a glioma diagnosis. JCI Insight. 8(19):e171225. https://doi.org/10.1172/jci.insight.171225 PMID:37651185
72. Luyapan J, Bossé Y, Li Z, Xiao X, Rosenberger A, Hung RJ, et al. (2023). Candidate pathway analysis of surfactant proteins identifies CTSH and SFTA2 that influences lung cancer risk. Hum Mol Genet. 32(18):2842–55. https://doi.org/10.1093/hmg/ddad095 PMID:37471639
73. M Filho A, Turner MC, Warnakulasuriya S, Richardson DB, Hosseini B, Kamangar F, et al. (2023). The carcinogenicity of opium consumption: a systematic review and meta-analysis. Eur J Epidemiol. 38(4):373–89. https://doi.org/10.1007/s10654-023-00969-7 PMID:36773182
74. Mälarstig A, Grassmann F, Dahl L, Dimitriou M, McLeod D, Gabrielson M, et al. (2023). Evaluation of circulating plasma proteins in breast cancer using Mendelian randomisation. Nat Commun. 14(1):7680. https://doi.org/10.1038/s41467-023-43485-8 PMID:37996402
75. Mangiante L, Alcala N, Sexton-Oates A, Di Genova A, Gonzalez-Perez A, Khandekar A, et al. (2023). Multiomic analysis of malignant pleural mesothelioma identifies molecular axes and specialized tumor profiles driving intertumor heterogeneity. Nat Genet. 55(4):607–18. https://doi.org/10.1038/s41588-023-01321-1 PMID:36928603
76. Matos LL, Kowalski LP, Chaves ALF, de Oliveira TB, Marta GN, Curado MP, et al.; HEADSpAcE Consortium (2024). Latin American Consensus on the Treatment of Head and Neck Cancer. JCO Glob Oncol. 10(10):e2300343. https://doi.org/10.1200/GO.23.00343 PMID:38603656
77. Midttun Ø, Ulvik A, Meyer K, Zahed H, Giles GG, Manjer J, et al. (2023). A cross-sectional study of inflammatory markers as determinants of circulating kynurenines in the Lung Cancer Cohort Consortium. Sci Rep. 13(1):1011. https://doi.org/10.1038/s41598-023-28135-9 PMID:36653422
78. Nalini M, Poustchi H, Roshandel G, Kamangar F, Khoshnia M, Gharavi A, et al. (2023). Association Between Incident Type 2 Diabetes and Opium Use: Mediation by Body Mass and Adiposity. Am J Epidemiol. 192(12):2050–62. https://doi.org/10.1093/aje/kwad166 PMID:37552966
79. Namaki M, Hashemian M, Arj A, Poustchi H, Roshandel G, Loghman AH, et al. (2023). Diet Quality and Subsequent Incidence of Upper Gastrointestinal Cancers: Results from the Golestan Cohort Study. Arch Iran Med. 26(9):489–98. https://doi.org/10.34172/aim.2023.74 PMID:38310404
80. Nemati S, Mohebbi E, Toorang F, Hadji M, Hosseini B, Saeedi E, et al. (2023). Population attributable proportion and number of cancer cases attributed to potentially modifiable risk factors in Iran in 2020. Int J Cancer. 153(10):1758–65. https://doi.org/10.1002/ijc.34659 PMID:37548110
81. Nemati S, Naji P, Abdi S, Lotfi F, Saeedi E, Mehravar SA, et al. (2023). National and Regional Fraction of Cancer Incidence and Death Attributable to Current Tobacco and Water-Pipe Smoking in the Eastern Mediterranean Countries in 2020. Nicotine Tob Res. 25(1):12–8. https://doi.org/10.1093/ntr/ntac179 PMID:35895382
82. Nemati S, Saeedi E, Lotfi F, Nahvijou A, Pirnejad H, Cheraghi M, et al. (2023). Regional disparities in cancer survival in Iran: Insight from a National Surveillance of Cancer Survival in Iran (IRANCANSURV). Cancer Epidemiol. 85:102378. https://doi.org/10.1016/j.canep.2023.102378 PMID:37229955
83. Nøst TH, Skogholt AH, Urbarova I, Mjelle R, Paulsen EE, Dønnem T, et al. (2023). Increased levels of microRNA-320 in blood serum and plasma is associated with imminent and advanced lung cancer. Mol Oncol. 17(2):312–27. https://doi.org/10.1002/1878-0261.13336 PMID:36337027
84. Papadimitriou N, Bull CJ, Jenab M, Hughes DJ, Bell JA, Sanderson E, et al. (2023). Separating the effects of early and later life adiposity on colorectal cancer risk: a Mendelian randomization study. BMC Med. 21(1):5. https://doi.org/10.1186/s12916-022-02702-9 PMID:36600297
85. Perim Galvão De Podestá O, Salaroli LB, Cattafesta M, Peres SV, De Podestá JRV, von Zeidler SLV, et al. (2023). Changes in Body Mass Index Are Associated with Squamous Cell Carcinomas of Oral Cavity, Oropharynx and Larynx: A Case-Control Study in Brazil. Nutr Cancer. 75(2):599–609. https://doi.org/10.1080/01635581.2022.2143535 PMID:36426640
86. Rashidian H, Hadji M, Gholipour M, Naghibzadeh-Tahami A, Marzban M, Mohebbi E, et al. (2023). Opium use and risk of lung cancer: A multicenter case-control study in Iran. Int J Cancer. 152(2):203–13. https://doi.org/10.1002/ijc.34244 PMID:36043555
87. Robbins HA, Alcala K, Moez EK, Guida F, Thomas S, Zahed H, et al. (2023). Design and methodological considerations for biomarker discovery and validation in the Integrative Analysis of Lung Cancer Etiology and Risk (INTEGRAL) Program. Ann Epidemiol. 77:1–12. https://doi.org/10.1016/j.annepidem.2022.10.014 PMID:36404465
88. Rogers M, Gill D, Ahlqvist E, Robinson T, Mariosa D, Johansson M, et al. (2023). Genetically proxied impaired GIPR signaling and risk of 6 cancers. iScience. 26(6):106848. https://doi.org/10.1016/j.isci.2023.106848 PMID:37250804
89. Sheikh M, Brennan P, Mariosa D, Robbins HA (2023). Opioid medications: an emerging cancer risk factor? Br J Anaesth. 130(3):e401–3. https://doi.org/10.1016/j.bja.2022.12.007 PMID:36682937
90. Sheikh M, Mukeriya A, Zahed H, Feng X, Robbins HA, Shangina O, et al. (2023). Smoking Cessation After Diagnosis of Kidney Cancer Is Associated With Reduced Risk of Mortality and Cancer Progression: A Prospective Cohort Study. J Clin Oncol. 41(15):2747–55. https://doi.org/10.1200/JCO.22.02472 PMID:36989465
91. Sheikh M, Roshandel G, McCormack V, Malekzadeh R (2023). Current Status and Future Prospects for Esophageal Cancer. Cancers (Basel). 15(3):765. https://doi.org/10.3390/cancers15030765 PMID:36765722
92. Sheikh M, Virani S, Robbins HA, Foretova L, Holcatova I, Janout V, et al. (2023). Survival and prognostic factors of early-stage non-small cell lung cancer in Central and Eastern Europe: A prospective cohort study. Cancer Med. 12(9):10563–74. https://doi.org/10.1002/cam4.5791 PMID:36952375
93. Shi J, Shiraishi K, Choi J, Matsuo K, Chen TY, Dai J, et al. (2023). Genome-wide association study of lung adenocarcinoma in East Asia and comparison with a European population. Nat Commun. 14(1):3043. https://doi.org/10.1038/s41467-023-38196-z PMID:37236969
94. Soroush A, Malekzadeh R, Roshandel G, Khoshnia M, Poustchi H, Kamangar F, et al. (2023). Sex and smoking differences in the association between gastroesophageal reflux and risk of esophageal squamous cell carcinoma in a high-incidence area: Golestan Cohort Study. Int J Cancer. 152(6):1137–49. https://doi.org/10.1002/ijc.34313 PMID:36214797
95. Sugier PE, Lucotte EA, Domenighetti C, Law MH, Iles MM, Brown K, et al.; EPITHYR consortium; Comprehensive Unbiased Risk Factor Assessment for Genetics and Environment in Parkinson’s Disease (Courage-PD) consortium (2023). Investigation of Shared Genetic Risk Factors Between Parkinson’s Disease and Cancers. Mov Disord. 38(4):604–15. https://doi.org/10.1002/mds.29337 PMID:36788297
96. Takata Y, Yang JJ, Yu D, Smith-Warner SA, Blot WJ, White E, et al. (2023). Calcium Intake and Lung Cancer Risk: A Pooled Analysis of 12 Prospective Cohort Studies. J Nutr. 153(7):2051–60. https://doi.org/10.1016/j.tjnut.2023.03.011 PMID:36907443
97. Vasudev NS, Scelo G, Glennon KI, Wilson M, Letourneau L, Eveleigh R, et al. (2023). Application of Genomic Sequencing to Refine Patient Stratification for Adjuvant Therapy in Renal Cell Carcinoma. Clin Cancer Res. 29(7):1220–31. https://doi.org/10.1158/1078-0432.CCR-22-1936 PMID:36815791
98. Wu WY, Haider Z, Feng X, Heath AK, Tjønneland A, Agudo A, et al. (2023). Assessment of the EarlyCDT-Lung test as an early biomarker of lung cancer in ever-smokers: A retrospective nested case-control study in two prospective cohorts. Int J Cancer. 152(9):2002–10. https://doi.org/10.1002/ijc.34340 PMID:36305647
99. Yammine SG, Huybrechts I, Biessy C, Dossus L, Panico S, Sánchez MJ, et al. (2023). Dietary fatty acids and endometrial cancer risk within the European Prospective Investigation into Cancer and Nutrition. BMC Cancer. 23(1):159. https://doi.org/10.1186/s12885-023-10611-0 PMID:36797668
100. Yarmolinsky J, Robinson JW, Mariosa D, Karhunen V, Huang J, Dimou N, et al.; International Lung Cancer Consortium; PRACTICAL Consortium (2024). Association between circulating inflammatory markers and adult cancer risk: a Mendelian randomization analysis. EBioMedicine. 100:104991. https://doi.org/10.1016/j.ebiom.2024.104991 PMID:38301482
101. Zvereva M, Hosen MI, Forey N, Sheikh M, Kannengiesser C, Ba I, et al. (2023). Simplex Droplet Digital PCR Assays for the Detection of TERT Promoter Mutations in Urine Samples for the Non-invasive Diagnosis of Urothelial Cancer. Methods Mol Biol. 2684:213–28. https://doi.org/10.1007/978-1-0716-3291-8_13 PMID:37410237
102. Alcala, K., Mariosa, D., Smith-Byrne, K., Nasrollahzadeh Nesheli, D., Carreras-Torres, R., Ardanaz Aicua, E., . . . Johansson, M. (2022). The relationship between blood pressure and risk of renal cell carcinoma. International Journal of Epidemiology. 51(4): 1317-1327. PMID: 35312764 https://doi.org/10.1093/ije/dyac042              
103. Alcala, N., & Rosenberg, N. A. (2022). Mathematical constraints on F(ST): multiallelic markers in arbitrarily many populations. Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences. 377(1852): 20200414. PMID: 35430885 https://doi.org/10.1098/rstb.2020.0414              
104. Berndt, S. I., Vijai, J., Benavente, Y., Camp, N. J., Nieters, A., Wang, Z., . . . Rothman, N. (2022). Distinct germline genetic susceptibility profiles identified for common non-Hodgkin lymphoma subtypes. Leukemia. 36(12): 2835-2844. PMID: 36273105 https://doi.org/10.1038/s41375-022-01711-0    
105. Bouras, E., Karhunen, V., Gill, D., Huang, J., Haycock, P. C., Gunter, M. J., . . . Tsilidis, K. K. (2022). Circulating inflammatory cytokines and risk of five cancers: a Mendelian randomization analysis. BMC Medicine. 20(1): 3. PMID: 35012533 https://doi.org/10.1186/s12916-021-02193-0    
106. Bouvard, V., Nethan, S. T., Singh, D., Warnakulasuriya, S., Mehrotra, R., Chaturvedi, A. K., . . . Lauby-Secretan, B. (2022). IARC Perspective on Oral Cancer Prevention. New England Journal of Medicine. 387(21): 1999-2005. PMID: 36378601 https://doi.org/10.1056/NEJMsr2210097             
107. Breeur, M., Ferrari, P., Dossus, L., Jenab, M., Johansson, M., Rinaldi, S., . . . Viallon, V. (2022). Pan-cancer analysis of pre-diagnostic blood metabolite concentrations in the European Prospective Investigation into Cancer and Nutrition. BMC Medicine. 20(1): 351. PMID: 36258205 https://doi.org/10.1186/s12916-022-02553-4        
108. Brennan, P., & Davey-Smith, G. (2022). Identifying Novel Causes of Cancers to Enhance Cancer Prevention: New Strategies Are Needed. Journal of the National Cancer Institute. 114(3): 353-360. PMID: 34743211 https://doi.org/10.1093/jnci/djab204               
109. Bukavina, L., Bensalah, K., Bray, F., Carlo, M., Challacombe, B., Karam, J. A., . . . Psutka, S. P. (2022). Epidemiology of Renal Cell Carcinoma: 2022 Update. European Urology. 82(5): 529-542. PMID: 36100483 https://doi.org/10.1016/j.eururo.2022.08.019
110. Byun, J., Han, Y., Li, Y., Xia, J., Long, E., Choi, J., . . . Amos, C. I. (2022). Cross-ancestry genome-wide meta-analysis of 61,047 cases and 947,237 controls identifies new susceptibility loci contributing to lung cancer. Nature Genetics. 54(8): 1167-1177. PMID: 35915169 https://doi.org/10.1038/s41588-022-01115-x  
111. Cai, J., Chen, H., Lu, M., Zhang, Y., Lu, B., Luo, C., . . . Zhao, Y. (2022). Association between Temporal Glycemic Change and Risk of Pancreatic Cancer in Men: A Prospective Cohort Study. Cancers. 14(14): 12. PMID: 35884465 https://doi.org/10.3390/cancers14143403          
112. Claeys, L., De Saeger, S., Scelo, G., Biessy, C., Casagrande, C., Nicolas, G., . . . Huybrechts, I. (2022). Mycotoxin Exposure and Renal Cell Carcinoma Risk: An Association Study in the EPIC European Cohort. Nutrients. 14(17): 3581. PMID: 36079840 https://doi.org/10.3390/nu14173581    
113. Clasen, J. L., Heath, A. K., Van Puyvelde, H., Huybrechts, I., Park, J. Y., Ferrari, P., . . . Muller, D. C. (2022). Biomarkers of the transsulfuration pathway and risk of renal cell carcinoma in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. International Journal of Cancer. 151(5): 708-716. PMID: 35366005 https://doi.org/10.1002/ijc.34009           
114. Collatuzzo, G., Etemadi, A., Sotoudeh, M., Nikmanesh, A., Poustchi, H., Khoshnia, M., . . . Malekzadeh, R. (2022). Meat consumption and risk of esophageal and gastric cancer in the Golestan Cohort Study, Iran. International Journal of Cancer. 151(7): 1005-1012. PMID: 35489023 https://doi.org/10.1002/ijc.34056            
115. Di Genova, A., Mangiante, L., Sexton-Oates, A., Voegele, C., Fernandez-Cuesta, L., Alcala, N., & Foll, M. (2022). A molecular phenotypic map of malignant pleural mesothelioma. Gigascience. 12. PMID: 36705549 https://doi.org/10.1093/gigascience/giac128  
116. Di Genova, A., Mangiante, L., Sexton-Oates, A., Voegele, C., Fernandez-Cuesta, L., Alcala, N., & Foll, M. (2022). A molecular phenotypic map of malignant pleural mesothelioma. Gigascience. 12: 13. PMID: 36705549 https://doi.org/10.1093/gigascience/giac128               
117. Dianatinasab, M., Wesselius, A., Salehi-Abargouei, A., Yu, E. Y. W., Fararouei, M., Brinkman, M., . . . Zeegers, M. P. (2022). Dietary fats and their sources in association with the risk of bladder cancer: A pooled analysis of 11 prospective cohort studies. International Journal of Cancer. 151(1): 44-55. PMID: 35182086 https://doi.org/10.1002/ijc.33970           
118. Ecke, T. H., Le Calvez-Kelm, F., & Otto, T. (2022). Molecular Diagnostic and Prognostication Assays for the Subtyping of Urinary Bladder Cancer Are on the Way to Illuminating Our Vision. International Journal of Molecular Sciences. 23(10): 5620. PMID: 35628431 https://doi.org/10.3390/ijms23105620            
119. Emerson, M. A., Farquhar, D. R., Lenze, N. R., Sheth, S., Mazul, A. L., Zanation, A. M., . . . Olshan, A. F. (2022). Socioeconomic status, access to care, risk factor patterns, and stage at diagnosis for head and neck cancer among black and white patients. Head and Neck. 44(4): 823-834. PMID: 35044015 https://doi.org/10.1002/hed.26977
120. Etemadi, A., Hariri, S., Hassanian-Moghaddam, H., Poustchi, H., Roshandel, G., Shayanrad, A., . . . Abnet, C. C. (2022). Lead poisoning among asymptomatic individuals with a long-term history of opiate use in Golestan Cohort Study. International Journal on Drug Policy. 104: 103695. PMID: 35472727 https://doi.org/10.1016/j.drugpo.2022.103695
121. Feng, X. S., Zahed, H., & Robbins, H. A. (2022). Editorial Comment. Journal of Urology. 207(2): 332. PMID: 34781695 https://doi.org/10.1097/JU.0000000000002249.01             
122. Gabriel, A. A. G., Atkins, J. R., Penha, R. C. C., Smith-Byrne, K., Gaborieau, V., Voegele, C., . . . McKay, J. D. (2022). Genetic Analysis of Lung Cancer and the Germline Impact on Somatic Mutation Burden. Journal of the National Cancer Institute. 114(8): 1159-1166. PMID: 35511172 https://doi.org/10.1093/jnci/djac087      
123. Galati, L., Combes, J. D., Le Calvez-Kelm, F., McKay-Chopin, S., Forey, N., Ratel, M., . . . Gheit, T. (2022). Detection of Circulating HPV16 DNA as a Biomarker for Cervical Cancer by a Bead-Based HPV Genotyping Assay. Microbiol Spectr. 10(2): e0148021. PMID: 35225653 https://doi.org/10.1128/spectrum.01480-21  
124. Gislon, L. C., Curado, M. P., Lopez, R. V. M., de Oliveira, J. C., Vasconcelos de Podesta, J. R., Ventorin von Zeidler, S., . . . Kowalski, L. P. (2022). Risk factors associated with head and neck cancer in former smokers: A Brazilian multicentric study. Cancer Epidemiology. 78: 102143. PMID: 35378425 https://doi.org/10.1016/j.canep.2022.102143    
125. Gormley, M., Dudding, T., Kachuri, L., Burrows, K., Chong, A. H. W., Martin, R. M., . . . Richmond, R. C. (2022). Investigating the effect of sexual behaviour on oropharyngeal cancer risk: a methodological assessment of Mendelian randomization. BMC Medicine. 20(1): 40. PMID: 35094705 https://doi.org/10.1186/s12916-022-02233-3    
126. Guida, F., Kidman, R., Ferlay, J., Schuz, J., Soerjomataram, I., Kithaka, B., . . . McCormack, V. (2022). Global and regional estimates of orphans attributed to maternal cancer mortality in 2020. Nature Medicine. 28(12): 2563-2572. PMID: 36404355 https://doi.org/10.1038/s41591-022-02109-2    
127. Hadji, M., Rashidian, H., Marzban, M., Naghibzadeh-Tahami, A., Gholipour, M., Mohebbi, E., . . . Pukkala, E. (2022). Opium use and risk of bladder cancer: a multi-centre case-referent study in Iran. International Journal of Epidemiology. 51(3): 830-838. PMID: 35244716 https://doi.org/10.1093/ije/dyac031
128. Hasanau, T., Pisarev, E., Kisil, O., Nonoguchi, N., Le Calvez-Kelm, F., & Zvereva, M. (2022). Detection of TERT Promoter Mutations as a Prognostic Biomarker in Gliomas: Methodology, Prospects, and Advances. Biomedicines. 10(3). PMID: 35327529 https://doi.org/10.3390/biomedicines10030728              
129. Hejazi, E., Emamat, H., Sharafkhah, M., Saidpour, A., Poustchi, H., Sepanlou, S., . . . Hekmatdoost, A. (2022). Dietary acid load and mortality from all causes, CVD and cancer: results from the Golestan Cohort Study. British Journal of Nutrition. 128(2): 237-243. PMID: 34392847 https://doi.org/10.1017/S0007114521003135              
130. Hemissi, I., Boussetta, S., Dallali, H., Hellal, F., Durand, G., Voegele, C., . . . Ouerhani, S. (2022). Development of a custom next-generation sequencing panel for the determination of bladder cancer risk in a Tunisian cohort. Molecular Biology Reports. 49(2): 1233-1258. PMID: 34854013 https://doi.org/10.1007/s11033-021-06951-4               
131. Hemissi, I., Boussetta, S., Dallali, H., Hellal, F., Durand, G., Voegele, C., . . . Ouerhani, S. (2022). Correction to: Development of a custom next-generation sequencing panel for the determination of bladder cancer risk in a Tunisian cohort. Molecular Biology Reports. 49(2): 1259. PMID: 34977990 https://doi.org/10.1007/s11033-021-07052-y               
132. Hong, W., Li, A., Liu, Y., Xiao, X., Christiani, D. C., Hung, R. J., . . . Cheng, C. (2022). Clonal Hematopoiesis Mutations in Patients with Lung Cancer Are Associated with Lung Cancer Risk Factors. Cancer Research. 82(2): 199-209. PMID: 34815255 https://doi.org/10.1158/0008-5472.CAN-21-1903            
133. Islam, S. M. A., Diaz-Gay, M., Wu, Y., Barnes, M., Vangara, R., Bergstrom, E. N., . . . Alexandrov, L. B. (2022). Uncovering novel mutational signatures by de novo extraction with SigProfilerExtractor. Cell Genom. 2(11): None. PMID: 36388765 https://doi.org/10.1016/j.xgen.2022.100179      
134. Kolijn, P. M., Hosnijeh, F. S., Spath, F., Hengeveld, P. J., Agathangelidis, A., Saleh, M., . . . Langerak, A. W. (2022). High-risk subtypes of chronic lymphocytic leukemia are detectable as early as 16 years prior to diagnosis. Blood. 139(10): 1557-1563. PMID: 34662377 https://doi.org/10.1182/blood.2021012890   
135. Li, M., Zhang, L., Charvat, H., Callister, M. E., Sasieni, P., Christodoulou, E., . . . Robbins, H. A. (2022). The influence of postscreening follow-up time and participant characteristics on estimates of overdiagnosis from lung cancer screening trials. International Journal of Cancer. 151(9): 1491-1501. PMID: 35809038 https://doi.org/10.1002/ijc.34167           
136. Li, Y., Xiao, X., Li, J., Byun, J., Cheng, C., Bosse, Y., . . . consortium, I.-I. l. c. (2022). Genome-wide interaction analysis identified low-frequency variants with sex disparity in lung cancer risk. Human Molecular Genetics. 31(16): 2831-2843. PMID: 35138370 https://doi.org/10.1093/hmg/ddac030  
137. Mariosa, D., Smith-Byrne, K., Richardson, T. G., Ferrari, P., Gunter, M. J., Papadimitriou, N., . . . Johansson, M. (2022). Body Size at Different Ages and Risk of 6 Cancers: A Mendelian Randomization and Prospective Cohort Study. Journal of the National Cancer Institute. 114(9): 1296-1300. PMID: 35438160 https://doi.org/10.1093/jnci/djac061     
138. Masukume, G., Mmbaga, B. T., Dzamalala, C. P., Mlombe, Y. B., Finch, P., Nyakunga-Maro, G., . . . McCormack, V. (2022). A very-hot food and beverage thermal exposure index and esophageal cancer risk in Malawi and Tanzania: findings from the ESCCAPE case-control studies. British Journal of Cancer. 127(6): 1106-1115. PMID: 35768549 https://doi.org/10.1038/s41416-022-01890-8    
139. Mc Leer, A., Foll, M., Brevet, M., Antoine, M., Novello, S., Mondet, J., . . . Moro-Sibilot, D. (2022). Detection of acquired TERT amplification in addition to predisposing p53 and Rb pathways alterations in EGFR-mutant lung adenocarcinomas transformed into small-cell lung cancers. Lung Cancer. 167: 98-106. PMID: 35183375 https://doi.org/10.1016/j.lungcan.2022.01.008
140. Middleton, D. R. S., Mmbaga, B. T., Menya, D., Dzamalala, C., Nyakunga-Maro, G., Finch, P., . . . Esccape (2022). Alcohol consumption and oesophageal squamous cell cancer risk in east Africa: findings from the large multicentre ESCCAPE case-control study in Kenya, Tanzania, and Malawi. Lancet Glob Health. 10(2): e236-e245. PMID: 34921758 https://doi.org/10.1016/S2214-109X(21)00506-4        
141. Moonen, L., Mangiante, L., Leunissen, D. J. G., Lap, L. M. V., Gabriel, A., Hillen, L. M., . . . Speel, E. M. (2022). Differential Orthopedia Homeobox expression in pulmonary carcinoids is associated with changes in DNA methylation. International Journal of Cancer. 150(12): 1987-1997. PMID: 35076935 https://doi.org/10.1002/ijc.33939               
142. Morrison, M. L., Alcala, N., & Rosenberg, N. A. (2022). FSTruct: An F(ST) -based tool for measuring ancestry variation in inference of population structure. Molecular Ecology Resources. 22(7): 2614-2626. PMID: 35596736 https://doi.org/10.1111/1755-0998.13647       
143. Mountzias, A., Hultdin, J., Hlodan, J., Kroger Dahlin, B. I., Johansson, M., & Ljungberg, B. (2022). Inflammatory response markers and survival prediction in patients with renal cell carcinoma. Scand J Urol. 56(1): 47-52. PMID: 34586034 https://doi.org/10.1080/21681805.2021.1983016           
144. Nomburg, J., Bullman, S., Nasrollahzadeh, D., Collisson, E. A., Abedi-Ardekani, B., Akoko, L. O., . . . Van Loon, K. (2022). An international report on bacterial communities in esophageal squamous cell carcinoma. International Journal of Cancer. 151(11): 1947-1959. PMID: 35837755 https://doi.org/10.1002/ijc.34212
145. Pakmanesh, H., Anvari, O., Forey, N., Weiderpass, E., Malekpourafshar, R., Iranpour, M., . . . Calvez-Kelm, F. L. (2022). TERT Promoter Mutations as Simple and Non-Invasive Urinary Biomarkers for the Detection of Urothelial Bladder Cancer in a High-Risk Region. International Journal of Molecular Sciences. 23(22): 14319. PMID: 36430798 https://doi.org/10.3390/ijms232214319              
146. Pastorino, R., Sassano, M., Danilo Tiziano, F., Giraldi, L., Amore, R., Arzani, D., . . . Boccia, S. (2022). Plasma miR-151-3p as a Candidate Diagnostic Biomarker for Head and Neck Cancer: A Cross-sectional Study within the INHANCE Consortium. Cancer Epidemiology, Biomarkers and Prevention. 31(12): 2237-2243. PMID: 36126276 https://doi.org/10.1158/1055-9965.EPI-22-0376              
147. Perdomo, S., Lopez, J., Torres-Ibarguen, M. Z., Puerto-Jimenez, D. N., & de Vries, E. (2022). Modelling the Reduction in Cancer Incidence After Variations in the Prevalence of Tobacco Consumption in Colombia in the Period 2016-2050. Cancer Control. 29: 10732748221121390. PMID: 36415920 https://doi.org/10.1177/10732748221121390   
148. Petrovic, D., Bodinier, B., Dagnino, S., Whitaker, M., Karimi, M., Campanella, G., . . . Chadeau-Hyam, M. (2022). Epigenetic mechanisms of lung carcinogenesis involve differentially methylated CpG sites beyond those associated with smoking. European Journal of Epidemiology. 37(6): 629-640. PMID: 35595947 https://doi.org/10.1007/s10654-022-00877-2     
149. Popovic, M., Fiano, V., Moirano, G., Chiusa, L., Conway, D. I., Garzino Demo, P., . . . Richiardi, L. (2022). The Impact of the COVID-19 Pandemic on Head and Neck Cancer Diagnosis in the Piedmont Region, Italy: Interrupted Time-Series Analysis. Front Public Health. 10: 809283. PMID: 35265573 https://doi.org/10.3389/fpubh.2022.809283           
150. Porta, M., Gasull, M., Pumarega, J., Kiviranta, H., Rantakokko, P., Raaschou-Nielsen, O., . . . Vineis, P. (2022). Plasma concentrations of persistent organic pollutants and pancreatic cancer risk. International Journal of Epidemiology. 51(2): 479-490. PMID: 34259837 https://doi.org/10.1093/ije/dyab115
151. Robbins, H. A., Cheung, L. C., Chaturvedi, A. K., Baldwin, D. R., Berg, C. D., & Katki, H. A. (2022). Management of Lung Cancer Screening Results Based on Individual Prediction of Current and Future Lung Cancer Risks. Journal of Thoracic Oncology. 17(2): 252-263. PMID: 34648946 https://doi.org/10.1016/j.jtho.2021.10.001       
152. Robbins, H. A., Ferreiro-Iglesias, A., Waterboer, T., Brenner, N., Nygard, M., Bender, N., . . . Brennan, P. (2022). Absolute Risk of Oropharyngeal Cancer After an HPV16-E6 Serology Test and Potential Implications for Screening: Results From the Human Papillomavirus Cancer Cohort Consortium. Journal of Clinical Oncology. 40(31): 3613-3622. PMID: 35700419 https://doi.org/10.1200/JCO.21.01785        
153. Robbins, H. A., Landy, R., & Ahluwalia, J. S. (2022). Achieving Equity in Lung Cancer Screening for Black Individuals Requires Innovation to Move Beyond « Equal » Guidelines. JAMA Oncol. 8(4): 1-2. PMID: 35201279 https://doi.org/10.1001/jamaoncol.2021.7252               
154. Robbins, H. A., Zahed, H., Lebrett, M. B., Balata, H., Johansson, M., Sharman, A., . . . Crosbie, P. A. J. (2022). Explaining differences in the frequency of lung cancer detection between the National Lung Screening Trial and community-based screening in Manchester, UK. Lung Cancer. 171: 61-64. PMID: 35917648 https://doi.org/10.1016/j.lungcan.2022.07.017
155. Rosenberger, A., Muttray, N., Hung, R. J., Christiani, D. C., Caporaso, N. E., Liu, G., . . . Consortium, I.-I. (2022). Gene-gene interaction of AhRwith and within the Wntcascade affects susceptibility to lung cancer. European Journal of Medical Research. 27(1): 14. PMID: 35101137 https://doi.org/10.1186/s40001-022-00638-7               
156. Schmid, S., Jiang, M., Brown, M. C., Fares, A., Garcia, M., Soriano, J., . . . Liu, G. (2022). Accounting for EGFR Mutations in Epidemiologic Analyses of Non-Small Cell Lung Cancers: Examples Based on the International Lung Cancer Consortium Data. Cancer Epidemiology, Biomarkers and Prevention. 31(3): 679-687. PMID: 35027437 https://doi.org/10.1158/1055-9965.EPI-21-0747              
157. Sichero, L., Tagliabue, M., Mota, G., Ferreira, S., Nunes, R. A. L., Castaneda, C. A., . . . Group, H. E. S. (2022). Biomarkers of human papillomavirus (HPV)-driven head and neck cancer in Latin America and Europe study: Study design and HPV DNA/p16(INK4a) status. Head and Neck. 44(1): 122-133. PMID: 34726297 https://doi.org/10.1002/hed.26912    
158. Simoens, C., Gheit, T., Ridder, R., Gorbaslieva, I., Holzinger, D., Lucas, E., . . . group, H.-A. s. (2022). Accuracy of high-risk HPV DNA PCR, p16((INK4a)) immunohistochemistry or the combination of both to diagnose HPV-driven oropharyngeal cancer. BMC Infectious Diseases. 22(1): 676. PMID: 35933382 https://doi.org/10.1186/s12879-022-07654-2     
159. Simon, J., Brenner, N., Reich, S., Langseth, H., Hansen, B. T., Ursin, G., . . . Waterboer, T. (2022). Nasopharyngeal carcinoma patients from Norway show elevated Epstein-Barr virus IgA and IgG antibodies prior to diagnosis. Cancer Epidemiology. 77: 102117. PMID: 35121404 https://doi.org/10.1016/j.canep.2022.102117
160. Smith-Byrne, K., Cerani, A., Guida, F., Zhou, S., Agudo, A., Aleksandrova, K., . . . Richards, J. B. (2022). Circulating Isovalerylcarnitine and Lung Cancer Risk: Evidence from Mendelian Randomization and Prediagnostic Blood Measurements. Cancer Epidemiology, Biomarkers and Prevention. 31(10): 1966-1974. PMID: 35839461 https://doi.org/10.1158/1055-9965.EPI-21-1033              
161. Tran, K. B., Lang, J. J., Compton, K., Xu, R. X., Acheson, A. R., Henrikson, H. J., . . . Murray, C. J. L. (2022). The global burden of cancer attributable to risk factors, 2010-19: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 400(10352): 563-591. PMID: 35988567 https://doi.org/10.1016/S0140-6736(22)01438-6            
162. Wade, K. H., Yarmolinsky, J., Giovannucci, E., Lewis, S. J., Millwood, I. Y., Munafo, M. R., . . . with the M. R. in Nutrition, C. w. g. (2022). Applying Mendelian randomization to appraise causality in relationships between nutrition and cancer. Cancer Causes and Control. 33(5): 631-652. PMID: 35274198 https://doi.org/10.1007/s10552-022-01562-1             
163. Watts, E. L., Perez-Cornago, A., Fensom, G. K., Smith-Byrne, K., Noor, U., Andrews, C. D., . . . Travis, R. C. (2022). Circulating free testosterone and risk of aggressive prostate cancer: Prospective and Mendelian randomisation analyses in international consortia. International Journal of Cancer. 151(7): 1033-1046. PMID: 35579976 https://doi.org/10.1002/ijc.34116           
164. Yang, J. J., Yu, D., White, E., Lee, D. H., Blot, W., Robien, K., . . . Shu, X. O. (2022). Prediagnosis Leisure-Time Physical Activity and Lung Cancer Survival: A Pooled Analysis of 11 Cohorts. JNCI Cancer Spectr. 6(2): 11. PMID: 35603841 https://doi.org/10.1093/jncics/pkac009
165. Yang, W., Liu, H., Zhang, R., Freedman, J. A., Han, Y., Hung, R. J., . . . Wei, Q. (2022). Deciphering associations between three RNA splicing-related genetic variants and lung cancer risk. NPJ Precis Oncol. 6(1): 48. PMID: 35773316 https://doi.org/10.1038/s41698-022-00281-9    
166. Yao, S., Campbell, P. T., Ugai, T., Gierach, G., Abubakar, M., Adalsteinsson, V., . . . Ogino, S. (2022). Proceedings of the fifth international Molecular Pathological Epidemiology (MPE) meeting. Cancer Causes and Control. 33(8): 1107-1120. PMID: 35759080 https://doi.org/10.1007/s10552-022-01594-7    
167. Yarmolinsky, J., Amos, C. I., Hung, R. J., Moreno, V., Burrows, K., Smith-Byrne, K., . . . Davey Smith, G. (2022). Association of germline TYK2 variation with lung cancer and non-Hodgkin lymphoma risk. International Journal of Cancer. 151(12): 2155-2160. PMID: 35747941 https://doi.org/10.1002/ijc.34180      
168. Zhang, R., Shen, S., Wei, Y., Zhu, Y., Li, Y., Chen, J., . . . Christiani, D. C. (2022). A Large-Scale Genome-Wide Gene-Gene Interaction Study of Lung Cancer Susceptibility in Europeans With a Trans-Ethnic Validation in Asians. Journal of Thoracic Oncology. 17(8): 974-990. PMID: 35500836 https://doi.org/10.1016/j.jtho.2022.04.011       
169. Abedi-Ardekani, B., Nasrollahzadeh, D., Egevad, L., Banks, R. E., Vasudev, N., Holcatova, I., . . . Scelo, G. (2021). Morphological findings in frozen non-neoplastic kidney tissues of patients with kidney cancer from large-scale multicentric studies on renal cancer. Virchows Arch. 478(6): 1099-1107. PMID: 33403511  doi: 10.1007/s00428-020-02986-3
170. Aredo, J. V., Luo, S. J., Gardner, R. M., Sanyal, N., Choi, E., Hickey, T. P., . . . Han, S. S. (2021). Tobacco Smoking and Risk of Second Primary Lung Cancer. J Thorac Oncol. 16(6): 968-979. PMID: 33722709  doi: 10.1016/j.jtho.2021.02.024
171. Baldwin, D. R., Callister, M. E., Crosbie, P. A., O’Dowd, E. L., Rintoul, R. C., Robbins, H. A., & Steele, R. J. C. (2021). Biomarkers in lung cancer screening: the importance of study design. Eur Respir J. 57(1). PMID: 33446580  doi: 10.1183/13993003.04367-2020
172. Barker, J., Smith-Byrne, K., Sayers, O., Joseph, K., Sleeman, M., Lasserson, D., & Vaux, E. (2021). Electronic alerts for acute kidney injury across primary and secondary care. BMJ Open Qual. 10(2): 7. PMID: 33972363  doi: 10.1136/bmjoq-2020-000956
173. Baumeister, S. E., Baurecht, H., Nolde, M., Alayash, Z., Glaser, S., Johansson, M., . . . Hung, R. J. (2021). Cannabis Use, Pulmonary Function, and Lung Cancer Susceptibility: A Mendelian Randomization Study. J Thorac Oncol. 16(7): 1127-1135. PMID: 33852959  doi: 10.1016/j.jtho.2021.03.025
174. Bray, M. J., Chen, L. S., Fox, L., Ma, Y., Grucza, R. A., Hartz, S. M., . . . Bierut, L. J. (2021). Studying the Utility of Using Genetics to Predict Smoking-Related Outcomes in a Population-Based Study and a Selected Cohort. Nicotine Tob Res. 23(12): 2110-2116. PMID: 33991188  doi: 10.1093/ntr/ntab100
175. Byun, J., Han, Y., Ostrom, Q. T., Edelson, J., Walsh, K. M., Pettit, R. W., . . . for, I.-I. (2021). The Shared Genetic Architectures Between Lung Cancer and Multiple Polygenic Phenotypes in Genome-Wide Association Studies. Cancer Epidemiol Biomarkers Prev. 30(6): 1156-1164. PMID: 33771847  doi: 10.1158/1055-9965.EPI-20-1635
176. Callister, M. E. J., Sasieni, P., & Robbins, H. A. (2021). Overdiagnosis in lung cancer screening. Lancet Respir Med. 9(1): 7-9. PMID: 33412118  doi: 10.1016/S2213-2600(20)30553-1
177. Chen, H., Majumdar, A., Wang, L., Kar, S., Brown, K. M., Feng, H., . . . Lindstrom, S. (2021). Large-scale cross-cancer fine-mapping of the 5p15.33 region reveals multiple independent signals. HGG Adv. 2(3): 100041. PMID: 34355204  doi: 10.1016/j.xhgg.2021.100041
178. Christakoudi, S., Pagoni, P., Ferrari, P., Cross, A. J., Tzoulaki, I., Muller, D. C., . . . Tsilidis, K. K. (2021). Weight change in middle adulthood and risk of cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Int J Cancer. 148(7): 1637-1651. PMID: 33038275  doi: 10.1002/ijc.33339
179. Clasen, J. L., Heath, A. K., Van Puyvelde, H., Huybrechts, I., Park, J. Y., Ferrari, P., . . . Muller, D. C. (2021). A comparison of complementary measures of vitamin B6 status, function, and metabolism in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Am J Clin Nutr. 114(1): 338-347. PMID: 33829249  doi: 10.1093/ajcn/nqab045
180. Collaboration, N. C. D. R. F. (2021). Heterogeneous contributions of change in population distribution of body mass index to change in obesity and underweight. Elife. 10. PMID: 33685583  doi: 10.7554/eLife.60060
181. Collaboration, N. C. D. R. F. (2021). Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet. 398(10304): 957-980. PMID: 34450083  doi: 10.1016/S0140-6736(21)01330-1
182. Conway, D. I., Hovanec, J., Ahrens, W., Ross, A., Holcatova, I., Lagiou, P., . . . McMahon, A. D. (2021). Occupational socioeconomic risk associations for head and neck cancer in Europe and South America: individual participant data analysis of pooled case-control studies within the INHANCE Consortium. J Epidemiol Community Health. 75(8): 779-787. PMID: 33622804  doi: 10.1136/jech-2020-214913
183. Cree, I. A., Indave Ruiz, B. I., Zavadil, J., McKay, J., Olivier, M., Kozlakidis, Z., . . . participants, I. R. (2021). The International Collaboration for Cancer Classification and Research. Int J Cancer. 148(3): 560-571. PMID: 32818326  doi: 10.1002/ijc.33260
184. Dagnino, S., Bodinier, B., Guida, F., Smith-Byrne, K., Petrovic, D., Whitaker, M. D., . . . Chadeau-Hyam, M. (2021). Prospective Identification of Elevated Circulating CDCP1 in Patients Years before Onset of Lung Cancer. Cancer Res. 81(13): 3738-3748. PMID: 33574093  doi: 10.1158/0008-5472.CAN-20-3454
185. Dianatinasab, M., Wesselius, A., de Loeij, T., Salehi-Abargouei, A., Yu, E. Y. W., Fararouei, M., . . . Zeegers, M. P. (2021). The association between meat and fish consumption and bladder cancer risk: a pooled analysis of 11 cohort studies. Eur J Epidemiol. 36(8): 781-792. PMID: 34036467  doi: 10.1007/s10654-021-00762-4
186. Dimou, N., Mori, N., Harlid, S., Harbs, J., Martin, R. M., Smith-Byrne, K., . . . Murphy, N. (2021). Circulating Levels of Testosterone, Sex Hormone Binding Globulin and Colorectal Cancer Risk: Observational and Mendelian Randomization Analyses. Cancer Epidemiol Biomarkers Prev. 30(7): 1336-1348. PMID: 33879453  doi: 10.1158/1055-9965.EPI-20-1690
187. Dimou, N. L., Papadimitriou, N., Mariosa, D., Johansson, M., Brennan, P., Peters, U., . . . Murphy, N. (2021). Circulating adipokine concentrations and risk of five obesity-related cancers: A Mendelian randomization study. Int J Cancer. 148(7): 1625-1636. PMID: 33038280  doi: 10.1002/ijc.33338
188. Fernandez-Cuesta, L., Mangiante, L., Alcala, N., & Foll, M. (2021). Challenges in lung and thoracic pathology: molecular advances in the classification of pleural mesotheliomas. Virchows Arch. 478(1): 73-80. PMID: 33411030  doi: 10.1007/s00428-020-02980-9
189. Ferreiro-Iglesias, A., McKay, J. D., Brenner, N., Virani, S., Lesseur, C., Gaborieau, V., . . . Brennan, P. (2021). Germline determinants of humoral immune response to HPV-16 protect against oropharyngeal cancer. Nat Commun. 12(1): 5945. PMID: 34642315  doi: 10.1038/s41467-021-26151-9
190. Ghasemi-Kebria, F., Jafari-Delouie, N., Amiriani, T., Norouzi, A., Abedi-Ardekani, B., Nasrollahzadeh, D., . . . Roshandel, G. (2021). Building a Cancer Biobank in a Low-Resource Setting in Northern Iran: the Golestan Cancer Biobank. Arch Iran Med. 24(7): 526-533. PMID: 34488317  doi: 10.34172/aim.2021.75
191. Ginsburg, O., Ashton-Prolla, P., Cantor, A., Mariosa, D., & Brennan, P. (2021). The role of genomics in global cancer prevention. Nat Rev Clin Oncol. 18(2): 116-128. PMID: 32973296  doi: 10.1038/s41571-020-0428-5
192. Gonzalez Maldonado, S., Hynes, L. C., Motsch, E., Heussel, C. P., Kauczor, H. U., Robbins, H. A., . . . Kaaks, R. (2021). Validation of multivariable lung cancer risk prediction models for the personalized assignment of optimal screening frequency: a retrospective analysis of data from the German Lung Cancer Screening Intervention Trial (LUSI). Transl Lung Cancer Res. 10(3): 1305-1317. PMID: 33889511  doi: 10.21037/tlcr-20-1173
193. Gormley, M., Yarmolinsky, J., Dudding, T., Burrows, K., Martin, R. M., Thomas, S., . . . Richmond, R. C. (2021). Using genetic variants to evaluate the causal effect of cholesterol lowering on head and neck cancer risk: A Mendelian randomization study. PLoS Genet. 17(4): e1009525. PMID: 33886544  doi: 10.1371/journal.pgen.1009525
194. Guida, F., Tan, V. Y., Corbin, L. J., Smith-Byrne, K., Alcala, K., Langenberg, C., . . . Johansson, M. (2021). The blood metabolome of incident kidney cancer: A case-control study nested within the MetKid consortium. PLoS Med. 18(9): e1003786. PMID: 34543281  doi: 10.1371/journal.pmed.1003786
195. Hadji, M., Rashidian, H., Marzban, M., Gholipour, M., Naghibzadeh-Tahami, A., Mohebbi, E., . . . Zendehdel, K. (2021). The Iranian Study of Opium and Cancer (IROPICAN): Rationale, Design, and Initial Findings. Arch Iran Med. 24(3): 167-176. PMID: 33878874  doi: 10.34172/aim.2021.27
196. Hashemian, M., Merat, S., Poustchi, H., Jafari, E., Radmard, A. R., Kamangar, F., . . . Etemadi, A. (2021). Red Meat Consumption and Risk of Nonalcoholic Fatty Liver Disease in a Population With Low Meat Consumption: The Golestan Cohort Study. Am J Gastroenterol. 116(8): 1667-1675. PMID: 33767101  doi: 10.14309/ajg.0000000000001229
197. Hubert, J. N., Suybeng, V., Vallee, M., Delhomme, T. M., Maubec, E., Boland, A., . . . Chanudet, E. (2021). The PI3K/mTOR Pathway Is Targeted by Rare Germline Variants in Patients with Both Melanoma and Renal Cell Carcinoma. Cancers (Basel). 13(9). PMID: 34067022  doi: 10.3390/cancers13092243
198. Hung, R. J., Warkentin, M. T., Brhane, Y., Chatterjee, N., Christiani, D. C., Landi, M. T., . . . Amos, C. I. (2021). Assessing Lung Cancer Absolute Risk Trajectory Based on a Polygenic Risk Model. Cancer Res. 81(6): 1607-1615. PMID: 33472890  doi: 10.1158/0008-5472.CAN-20-1237
199. Julian-Serrano, S., Yuan, F., Wheeler, W., Benyamin, B., Machiela, M. J., Arslan, A. A., . . . Stolzenberg-Solomon, R. Z. (2021). Hepcidin-regulating iron metabolism genes and pancreatic ductal adenocarcinoma: a pathway analysis of genome-wide association studies. Am J Clin Nutr. 114(4): 1408-1417. PMID: 34258619  doi: 10.1093/ajcn/nqab217
200. Kliemann, N., Viallon, V., Murphy, N., Beeken, R. J., Rothwell, J. A., Rinaldi, S., . . . Gunter, M. J. (2021). Metabolic signatures of greater body size and their associations with risk of colorectal and endometrial cancers in the European Prospective Investigation into Cancer and Nutrition. BMC Med. 19(1): 101. PMID: 33926456  doi: 10.1186/s12916-021-01970-1
201. Landy, R., Young, C. D., Skarzynski, M., Cheung, L. C., Berg, C. D., Rivera, M. P., . . . Katki, H. A. (2021). Using Prediction Models to Reduce Persistent Racial and Ethnic Disparities in the Draft 2020 USPSTF Lung Cancer Screening Guidelines. J Natl Cancer Inst. 113(11): 1590-1594. PMID: 33399825  doi: 10.1093/jnci/djaa211
202. Laskar, R., Ferreiro-Iglesias, A., Bishop, D. T., Iles, M. M., Kanetsky, P. A., Armstrong, B. K., . . . Cust, A. E. (2021). Risk factors for melanoma by anatomical site: an evaluation of aetiological heterogeneity. Br J Dermatol. 184(6): 1085-1093. PMID: 33270213  doi: 10.1111/bjd.19705
203. Laskar, R. S., Li, P., Ecsedi, S., Abedi-Ardekani, B., Durand, G., Robinot, N., . . . Chanudet, E. (2021). Sexual dimorphism in cancer: insights from transcriptional signatures in kidney tissue and renal cell carcinoma. Hum Mol Genet. 30(5): 343-355. PMID: 33527138  doi: 10.1093/hmg/ddab031
204. Lesseur, C., Ferreiro-Iglesias, A., McKay, J. D., Bosse, Y., Johansson, M., Gaborieau, V., . . . Brennan, P. (2021). Genome-wide association meta-analysis identifies pleiotropic risk loci for aerodigestive squamous cell cancers. PLoS Genet. 17(3): e1009254. PMID: 33667223  doi: 10.1371/journal.pgen.1009254
205. Liu, Y., Xia, J., McKay, J., Tsavachidis, S., Xiao, X., Spitz, M. R., . . . Amos, C. I. (2021). Rare deleterious germline variants and risk of lung cancer. NPJ Precis Oncol. 5(1): 12. PMID: 33594163  doi: 10.1038/s41698-021-00146-7
206. Liu, Z., Derkach, A., Yu, K. J., Yeager, M., Chang, Y. S., Chen, C. J., . . . Pfeiffer, R. M. (2021). Patterns of Human Leukocyte Antigen Class I and Class II Associations and Cancer. Cancer Res. 81(4): 1148-1152. PMID: 33272927  doi: 10.1158/0008-5472.CAN-20-2292
207. Loftfield, E., Stepien, M., Viallon, V., Trijsburg, L., Rothwell, J. A., Robinot, N., . . . Ferrari, P. (2021). Novel Biomarkers of Habitual Alcohol Intake and Associations With Risk of Pancreatic and Liver Cancers and Liver Disease Mortality. J Natl Cancer Inst. 113(11): 1542-1550. PMID: 34010397  doi: 10.1093/jnci/djab078
208. Lopez de Maturana, E., Rodriguez, J. A., Alonso, L., Lao, O., Molina-Montes, E., Martin-Antoniano, I. A., . . . Malats, N. (2021). A multilayered post-GWAS assessment on genetic susceptibility to pancreatic cancer. Genome Med. 13(1): 15. PMID: 33517887  doi: 10.1186/s13073-020-00816-4
209. Martínez-Gregorio, H., Rojas-Jiménez, E., Mejía-Gómez, J. C., Díaz-Velásquez, C., Quezada-Urban, R., Vallejo-Lecuona, F., . . . Vaca-Paniagua, F. (2021). The Evolution of Clinically Aggressive Triple-Negative Breast Cancer Shows a Large Mutational Diversity and Early Metastasis to Lymph Nodes. Cancers (Basel). 13(20). PMID: 34680239  doi: 10.3390/cancers13205091
210. Middleton, D. R. S., Mmbaga, B. T., O’Donovan, M., Abedi-Ardekani, B., Debiram-Beecham, I., Nyakunga-Maro, G., . . . McCormack, V. (2021). Minimally invasive esophageal sponge cytology sampling is feasible in a Tanzanian community setting. Int J Cancer. 148(5): 1208-1218. PMID: 33128785  doi: 10.1002/ijc.33366
211. Miranda-Filho, A., Charvat, H., Bray, F., Migowski, A., Cheung, L. C., Vaccarella, S., . . . Robbins, H. A. (2021). A modeling analysis to compare eligibility strategies for lung cancer screening in Brazil. EClinicalMedicine. 42: 101176. PMID: 34765952  doi: 10.1016/j.eclinm.2021.101176
212. Mocci, E., Kundu, P., Wheeler, W., Arslan, A. A., Beane-Freeman, L. E., Bracci, P. M., . . . Stolzenberg-Solomon, R. (2021). Smoking Modifies Pancreatic Cancer Risk Loci on 2q21.3. Cancer Res. 81(11): 3134-3143. PMID: 33574088  doi: 10.1158/0008-5472.CAN-20-3267
213. Mohebbi, E., Hadji, M., Rashidian, H., Rezaianzadeh, A., Marzban, M., Haghdoost, A. A., . . . Zendehdel, K. (2021). Opium use and the risk of head and neck squamous cell carcinoma. Int J Cancer. 148(5): 1066-1076. PMID: 32895947  doi: 10.1002/ijc.33289
214. Moody, S., Senkin, S., Islam, S. M. A., Wang, J., Nasrollahzadeh, D., Cortez Cardoso Penha, R., . . . Stratton, M. R. (2021). Mutational signatures in esophageal squamous cell carcinoma from eight countries with varying incidence. Nat Genet. 53(11): 1553-1563. PMID: 34663923  doi: 10.1038/s41588-021-00928-6
215. Moore, A., Machiela, M. J., Machado, M., Wang, S. S., Kane, E., Slager, S. L., . . . Berndt, S. I. (2021). Genome-wide homozygosity and risk of four non-Hodgkin lymphoma subtypes. J Transl Genet Genom. 5: 200-217. PMID: 34622145  doi: 10.20517/jtgg.2021.08
216. Mullins, N., Forstner, A. J., O’Connell, K. S., Coombes, B., Coleman, J. R. I., Qiao, Z., . . . Andreassen, O. A. (2021). Genome-wide association study of more than 40,000 bipolar disorder cases provides new insights into the underlying biology. Nat Genet. 53(6): 817-829. PMID: 34002096  doi: 10.1038/s41588-021-00857-4
217. Nalini, M., Khoshnia, M., Kamangar, F., Sharafkhah, M., Poustchi, H., Pourshams, A., . . . Etemadi, A. (2021). Joint effect of diabetes and opiate use on all-cause and cause-specific mortality: the Golestan cohort study. Int J Epidemiol. 50(1): 314-324. PMID: 32810213  doi: 10.1093/ije/dyaa126
218. Nalini, M., Khoshnia, M., Kamangar, F., Sharafkhah, M., Poustchi, H., Pourshams, A., . . . Etemadi, A. (2021). Corrigendum to: Joint effect of diabetes and opiate use on all-cause and cause-specific mortality: the Golestan cohort study. Int J Epidemiol. 50(1): 353. PMID: 33367601  doi: 10.1093/ije/dyaa268
219. Nasrollahzadeh, D., Roshandel, G., Delhomme, T. M., Avogbe, P. H., Foll, M., Saidi, F., . . . Abedi-Ardekani, B. (2021). TP53 Targeted Deep Sequencing of Cell-Free DNA in Esophageal Squamous Cell Carcinoma Using Low-Quality Serum: Concordance with Tumor Mutation. Int J Mol Sci. 22(11). PMID: 34073316  doi: 10.3390/ijms22115627
220. Nazarzadeh, M., Bidel, Z., Canoy, D., Copland, E., Wamil, M., Majert, J., . . . Blood Pressure Lowering Treatment Trialists, C. (2021). Blood pressure lowering and risk of new-onset type 2 diabetes: an individual participant data meta-analysis. Lancet. 398(10313): 1803-1810. PMID: 34774144  doi: 10.1016/S0140-6736(21)01920-6
221. Nost, T. H., Alcala, K., Urbarova, I., Byrne, K. S., Guida, F., Sandanger, T. M., & Johansson, M. (2021). Systemic inflammation markers and cancer incidence in the UK Biobank. Eur J Epidemiol. 36(8): 841-848. PMID: 34036468  doi: 10.1007/s10654-021-00752-6
222. Pettit, R. W., Byun, J., Han, Y., Ostrom, Q. T., Edelson, J., Walsh, K. M., . . . Amos, C. I. (2021). The shared genetic architecture between epidemiological and behavioral traits with lung cancer. Sci Rep. 11(1): 17559. PMID: 34475455  doi: 10.1038/s41598-021-96685-x
223. Purdue, M. P., Rhee, J., Moore, L., Gao, X., Sun, X., Kirk, E., . . . Rothman, N. (2021). Differences in risk factors for molecular subtypes of clear cell renal cell carcinoma. Int J Cancer. 149(7): 1448-1454. PMID: 34058014  doi: 10.1002/ijc.33701
224. Qin, N., Li, Y., Wang, C., Zhu, M., Dai, J., Hong, T., . . . Shen, H. (2021). Comprehensive functional annotation of susceptibility variants identifies genetic heterogeneity between lung adenocarcinoma and squamous cell carcinoma. Front Med. 15(2): 275-291. PMID: 32889700  doi: 10.1007/s11684-020-0779-4
225. Ramakrishnan, R., Doherty, A., Smith-Byrne, K., Rahimi, K., Bennett, D., Woodward, M., . . . Dwyer, T. (2021). Accelerometer measured physical activity and the incidence of cardiovascular disease: Evidence from the UK Biobank cohort study. PLoS Med. 18(1): e1003487. PMID: 33434193  doi: 10.1371/journal.pmed.1003487
226. Riscal, R., Bull, C. J., Mesaros, C., Finan, J. M., Carens, M., Ho, E. S., . . . Simon, M. C. (2021). Cholesterol Auxotrophy as a Targetable Vulnerability in Clear Cell Renal Cell Carcinoma. Cancer Discov. 11(12): 3106-3125. PMID: 34244212  doi: 10.1158/2159-8290.CD-21-0211
227. Robbins, H. A., Alcala, K., Swerdlow, A. J., Schoemaker, M. J., Wareham, N., Travis, R. C., . . . Johansson, M. (2021). Comparative performance of lung cancer risk models to define lung screening eligibility in the United Kingdom. Br J Cancer. 124(12): 2026-2034. PMID: 33846525  doi: 10.1038/s41416-021-01278-0
228. Rostron, B. L., Wang, J., Etemadi, A., Thakur, S., Chang, J. T., Bhandari, D., . . . Chang, C. M. (2021). Associations between Biomarkers of Exposure and Lung Cancer Risk among Exclusive Cigarette Smokers in the Golestan Cohort Study. Int J Environ Res Public Health. 18(14). PMID: 34299799  doi: 10.3390/ijerph18147349
229. Saberi Hosnijeh, F., Casabonne, D., Nieters, A., Solans, M., Naudin, S., Ferrari, P., . . . Vermeulen, R. (2021). Association between anthropometry and lifestyle factors and risk of B-cell lymphoma: An exposome-wide analysis. Int J Cancer. 148(9): 2115-2128. PMID: 33128820  doi: 10.1002/ijc.33369
230. Senkin, S. (2021). MSA: reproducible mutational signature attribution with confidence based on simulations. BMC Bioinformatics. 22(1): 540. PMID: 34736398  doi: 10.1186/s12859-021-04450-8
231. Seyed Khoei, N., Carreras-Torres, R., Murphy, N., Gunter, M. J., Brennan, P., Smith-Byrne, K., . . . Freisling, H. (2021). Genetically Raised Circulating Bilirubin Levels and Risk of Ten Cancers: A Mendelian Randomization Study. Cells. 10(2). PMID: 33671849  doi: 10.3390/cells10020394
232. Sheikh, M., Mukeriya, A., Shangina, O., Brennan, P., & Zaridze, D. (2021). Postdiagnosis Smoking Cessation and Reduced Risk for Lung Cancer Progression and Mortality : A Prospective Cohort Study. Ann Intern Med. 174(9): 1232-1239. PMID: 34310171  doi: 10.7326/M21-0252
233. Sheth, S., Farquhar, D. R., Lenze, N. R., Mazul, A., Brennan, P., Anantharaman, D., . . . Olshan, F. (2021). Decreased overall survival in black patients with HPV-associated oropharyngeal cancer. Am J Otolaryngol. 42(1): 102780. PMID: 33152576  doi: 10.1016/j.amjoto.2020.102780
234. Simoens, C., Gorbaslieva, I., Gheit, T., Holzinger, D., Lucas, E., Ridder, R., . . . group, H.-A. s. (2021). HPV DNA genotyping, HPV E6*I mRNA detection, and p16(INK4a)/Ki-67 staining in Belgian head and neck cancer patient specimens, collected within the HPV-AHEAD study. Cancer Epidemiol. 72: 101925. PMID: 33839457  doi: 10.1016/j.canep.2021.101925
235. Singleton, R. K., Heath, A. K., Clasen, J. L., Scelo, G., Johansson, M., Calvez-Kelm, F. L., . . . Muller, D. C. (2021). Risk Prediction for Renal Cell Carcinoma: Results from the European Prospective Investigation into Cancer and Nutrition (EPIC) Prospective Cohort Study. Cancer Epidemiol Biomarkers Prev. 30(3): 507-512. PMID: 33335022  doi: 10.1158/1055-9965.EPI-20-1438
236. Sklias, A., Halaburkova, A., Vanzan, L., Jimenez, N. F., Cuenin, C., Bouaoun, L., . . . Herceg, Z. (2021). Epigenetic remodelling of enhancers in response to estrogen deprivation and re-stimulation. Nucleic Acids Res. 49(17): 9738-9754. PMID: 34403459  doi: 10.1093/nar/gkab697
237. Sun, R., Xu, M., Li, X., Gaynor, S., Zhou, H., Li, Z., . . . Lin, X. (2021). Integration of multiomic annotation data to prioritize and characterize inflammation and immune-related risk variants in squamous cell lung cancer. Genet Epidemiol. 45(1): 99-114. PMID: 32924180  doi: 10.1002/gepi.22358
238. Sun, Y. Q., Richmond, R. C., Suderman, M., Min, J. L., Battram, T., Flatberg, A., . . . Mai, X. M. (2021). Assessing the role of genome-wide DNA methylation between smoking and risk of lung cancer using repeated measurements: the HUNT study. Int J Epidemiol. 50(5): 1482-1497. PMID: 33729499  doi: 10.1093/ije/dyab044
239. Talukdar, F. R., Soares Lima, S. C., Khoueiry, R., Laskar, R. S., Cuenin, C., Sorroche, B. P., . . . Herceg, Z. (2021). Genome-Wide DNA Methylation Profiling of Esophageal Squamous Cell Carcinoma from Global High-Incidence Regions Identifies Crucial Genes and Potential Cancer Markers. Cancer Res. 81(10): 2612-2624. PMID: 33741694  doi: 10.1158/0008-5472.CAN-20-3445
240. Viallon, V., His, M., Rinaldi, S., Breeur, M., Gicquiau, A., Hemon, B., . . . Ferrari, P. (2021). A New Pipeline for the Normalization and Pooling of Metabolomics Data. Metabolites. 11(9). PMID: 34564446  doi: 10.3390/metabo11090631
241. Virani, S., Baiocchi, G., Bowtell, D., Cabasag, C. J., Cho, K. R., Fortner, R. T., . . . Trabert, B. (2021). Joint IARC/NCI International Cancer Seminar Series Report: expert consensus on future directions for ovarian carcinoma research. Carcinogenesis. 42(6): 785-793. PMID: 34037709  doi: 10.1093/carcin/bgab043
242. Waller, R. G., Klein, R. J., Vijai, J., McKay, J. D., Clay-Gilmour, A., Wei, X., . . . Camp, N. J. (2021). Sequencing at lymphoid neoplasm susceptibility loci maps six myeloma risk genes. Hum Mol Genet. 30(12): 1142-1153. PMID: 33751038  doi: 10.1093/hmg/ddab066
243. Watts, E. L., Fensom, G. K., Smith Byrne, K., Perez-Cornago, A., Allen, N. E., Knuppel, A., . . . Travis, R. C. (2021). Circulating insulin-like growth factor-I, total and free testosterone concentrations and prostate cancer risk in 200 000 men in UK Biobank. Int J Cancer. 148(9): 2274-2288. PMID: 33252839  doi: 10.1002/ijc.33416
244. Yano, Y., Abnet, C. C., Poustchi, H., Roshandel, G., Pourshams, A., Islami, F., . . . Etemadi, A. (2021). Oral Health and Risk of Upper Gastrointestinal Cancers in a Large Prospective Study from a High-risk Region: Golestan Cohort Study. Cancer Prev Res (Phila). 14(7): 709-718. PMID: 33731409  doi: 10.1158/1940-6207.Capr-20-0577
245. Yu, E. Y., Wesselius, A., Mehrkanoon, S., Goosens, M., Brinkman, M., van den Brandt, P., . . . Zeegers, M. P. (2021). Vegetable intake and the risk of bladder cancer in the BLadder Cancer Epidemiology and Nutritional Determinants (BLEND) international study. BMC Med. 19(1): 56. PMID: 33685459  doi: 10.1186/s12916-021-01931-8
246. Zahed, H., Johansson, M., Ueland, P. M., Midttun, O., Milne, R. L., Giles, G. G., . . . Robbins, H. A. (2021). Epidemiology of 40 blood biomarkers of one-carbon metabolism, vitamin status, inflammation, and renal and endothelial function among cancer-free older adults. Sci Rep. 11(1): 13805. PMID: 34226613  doi: 10.1038/s41598-021-93214-8
247. Zhou, W., Liu, G., Hung, R. J., Haycock, P. C., Aldrich, M. C., Andrew, A. S., . . . Amos, C. I. (2021). Causal relationships between body mass index, smoking and lung cancer: Univariable and multivariable Mendelian randomization. Int J Cancer. 148(5): 1077-1086. PMID: 32914876  doi: 10.1002/ijc.33292
248. Abrahao, R., Perdomo, S., Pinto, L. F. R., Nascimento de Carvalho, F., Dias, F. L., de Podesta, J. R. V., . . . Curado, M. P. (2020). Predictors of Survival After Head and Neck Squamous Cell Carcinoma in South America: The InterCHANGE Study. JCO Glob Oncol. 6: 486-499. PMID: 32213095 doi: 10.1200/go.20.00014
249. Bosse, Y., Li, Z., Xia, J., Manem, V., Carreras-Torres, R., Gabriel, A., . . . McKay, J. D. (2020). Transcriptome-wide association study reveals candidate causal genes for lung cancer. Int J Cancer. 146(7): 1862-1878. PMID: 31696517 doi: 10.1002/ijc.32771
250. Bray, M. J., Chen, L. S., Fox, L., Hancock, D. B., Culverhouse, R. C., Hartz, S. M., . . . Bierut, L. J. (2020). Dissecting the genetic overlap of smoking behaviors, lung cancer, and chronic obstructive pulmonary disease: A focus on nicotinic receptors and nicotine metabolizing enzyme. Genet Epidemiol. 44(7): 748-758. PMID: 32803792 doi: 10.1002/gepi.22331
251. Brhane, Y., Yang, P., Christiani, D. C., Liu, G., McLaughlin, J. R., Brennan, P., . . . Hung, R. J. (2020). Genetic Determinants of Lung Cancer Prognosis in Never Smokers: A Pooled Analysis in the International Lung Cancer Consortium. Cancer Epidemiol Biomarkers Prev. 29(10): 1983-1992. PMID: 32699080 doi: 10.1158/1055-9965.Epi-20-0248
252. Buexm, L. A., Soares-Lima, S. C., Brennan, P., Fernandes, P. V., de Souza Almeida Lopes, M., Nascimento de Carvalho, F., . . . Ribeiro Pinto, L. F. (2020). Hpv impact on oropharyngeal cancer patients treated at the largest cancer center from Brazil. Cancer Lett. 477: 70-75. PMID: 32087309 doi: 10.1016/j.canlet.2020.02.023
253. Chen, C., Lohavanichbutr, P., Zhang, Y., Houck, J. R., Upton, M. P., Abedi-Ardekani, B., . . . Wang, P. (2020). Prediction of survival of HPV16-negative, p16-negative oral cavity cancer patients using a 13-gene signature: A multicenter study using FFPE samples. Oral Oncol. 100: 104487. PMID: 31835136 doi: 10.1016/j.oraloncology.2019.104487
254. Christakoudi, S., Kakourou, A., Markozannes, G., Tzoulaki, I., Weiderpass, E., Brennan, P., . . . Tsilidis, K. K. (2020). Blood pressure and risk of cancer in the European Prospective Investigation into Cancer and Nutrition. Int J Cancer. 146(10): 2680-2693. PMID: 31319002 doi: 10.1002/ijc.32576
255. Clasen, J. L., Heath, A. K., Scelo, G., & Muller, D. C. (2020). Components of one-carbon metabolism and renal cell carcinoma: a systematic review and meta-analysis. Eur J Nutr. 59(8): 3801-3813. PMID: 32162043 doi: 10.1007/s00394-020-02211-6
256. Cohen, D., Ghosh, S., Shimakawa, Y., Ramou, N., Garcia, P. S., Dubois, A., . . . Chemin, I. (2020). Hepatitis B virus preS2Δ38-55 variants: A newly identified risk factor for hepatocellular carcinoma. JHEP Rep. 2(5): 100144. PMID: 32904132 doi: 10.1016/j.jhepr.2020.100144
257. Consortium, I. T. P.-C. A. o. W. G. (2020). Pan-cancer analysis of whole genomes. Nature. 578(7793): 82-93. PMID: 32025007 doi: 10.1038/s41586-020-1969-6
258. Cristiano, S., McKean, D., Carey, J., Bracci, P., Brennan, P., Chou, M., . . . Scharpf, R. B. (2020). Bayesian copy number detection and association in large-scale studies. BMC cancer. 20(1): 856. PMID: 32894098 doi: 10.1186/s12885-020-07304-3
259. Dagnino, S., Bodinier, B., Grigoryan, H., Rappaport, S. M., Karimi, M., Guida, F., . . . Chadeau-Hyam, M. (2020). Agnostic Cys34-albumin adductomics and DNA methylation: Implication of N-acetylcysteine in lung carcinogenesis years before diagnosis. Int J Cancer. 146(12): 3294-3303. PMID: 31513294 doi: 10.1002/ijc.32680
260. Dai, J., Huang, M., Amos, C. I., Hung, R. J., Tardon, A., Andrew, A., . . . Shen, H. (2020). Genome-wide association study of INDELs identified four novel susceptibility loci associated with lung cancer risk. Int J Cancer. 146(10): 2855-2864. PMID: 31577861 doi: 10.1002/ijc.32698
261. de Carvalho, A. C., Perdomo, S., Dos Santos, W., Fernandes, G. C., de Jesus, L. M., Carvalho, R. S., . . . Carvalho, A. L. (2020). Impact of genetic variants in clinical outcome of a cohort of patients with oropharyngeal squamous cell carcinoma. Sci Rep. 10(1): 9970. PMID: 32561788 doi: 10.1038/s41598-020-66741-z
262. Di Credico, G., Polesel, J., Dal Maso, L., Pauli, F., Torelli, N., Luce, D., . . . Edefonti, V. (2020). Alcohol drinking and head and neck cancer risk: the joint effect of intensity and duration. Br J Cancer. 123(9): 1456-1463. PMID: 32830199 doi: 10.1038/s41416-020-01031-z
263. Dianatinasab, M., Wesselius, A., Salehi-Abargouei, A., Yu, E. Y. W., Brinkman, M., Fararouei, M., . . . Zeegers, M. P. (2020). Adherence to a Western dietary pattern and risk of bladder cancer: A pooled analysis of 13 cohort studies of the Bladder Cancer Epidemiology and Nutritional Determinants international study. Int J Cancer. 147(12): 3394-3403. PMID: 32580241 doi: 10.1002/ijc.33173
264. Ecke, T. H., Otto, T., & Le Calvez-Kelm, F. (2020). Evaluating the Utility of Combined Bladder Cancer Biomarkers, the Molecular Prognostication of Tumor Subtypes, or What Else Is Needed to Illuminate Our Vision? International Journal of Molecular Sciences. 21(24): 3. PMID: 33352845 doi: 10.3390/ijms21249657
265. Etemadi, A., Poustchi, H., Calafat, A. M., Blount, B. C., De Jesus, V. R., Wang, L., . . . Freedman, N. D. (2020). Opiate and Tobacco Use and Exposure to Carcinogens and Toxicants in the Golestan Cohort Study. Cancer Epidemiol Biomarkers Prev. 29(3): 650-658. PMID: 31915141 doi: 10.1158/1055-9965.Epi-19-1212
266. Farquhar, D. R., Coniglio, A. J., Masood, M. M., Lenze, N., Brennan, P., Anantharaman, D., . . . Hackman, T. G. (2020). Evaluation of pathologic staging using number of nodes in p16-negative head and neck cancer. Oral Oncol. 108: 104800. PMID: 32492516 doi: 10.1016/j.oraloncology.2020.104800
267. Gabriel, A. A. G., Mathian, E., Mangiante, L., Voegele, C., Cahais, V., Ghantous, A., . . . Foll, M. (2020). A molecular map of lung neuroendocrine neoplasms. Gigascience. 9(11). PMID: 33124659 doi: 10.1093/gigascience/giaa112
268. Galateau Salle, F., Le Stang, N., Tirode, F., Courtiol, P., Nicholson, A. G., Tsao, M. S., . . . Girard, N. (2020). Comprehensive Molecular and Pathologic Evaluation of Transitional Mesothelioma Assisted by Deep Learning Approach: A Multi-Institutional Study of the International Mesothelioma Panel from the MESOPATH Reference Center. J Thorac Oncol. 15(6): 1037-1053. PMID: 32165206 doi: 10.1016/j.jtho.2020.01.025
269. Galimberti, M., Leuenberger, C., Wolf, B., Szilágyi, S. M., Foll, M., & Wegmann, D. (2020). Detecting Selection from Linked Sites Using an F-Model. Genetics. 216(4): 1205-1215. PMID: 33067324 doi: 10.1534/genetics.120.303780
270. Ghoneim, D. H., Zhu, J., Zheng, W., Long, J., Murff, H. J., Ye, F., . . . Wu, L. (2020). Mendelian Randomization Analysis of n-6 Polyunsaturated Fatty Acid Levels and Pancreatic Cancer Risk. Cancer Epidemiol Biomarkers Prev. 29(12): 2735-2739. PMID: 32967863 doi: 10.1158/1055-9965.Epi-20-0651
271. Gormley, M., Dudding, T., Sanderson, E., Martin, R. M., Thomas, S., Tyrrell, J., . . . Richmond, R. C. (2020). A multivariable Mendelian randomization analysis investigating smoking and alcohol consumption in oral and oropharyngeal cancer. Nat Commun. 11(1): 6071. PMID: 33247085 doi: 10.1038/s41467-020-19822-6
272. Gupta, P., Shahzad, N., Harold, A., Shuda, M., Venuti, A., Romero-Medina, M. C., . . . Tommasino, M. (2020). Merkel Cell Polyomavirus Downregulates N-myc Downstream-Regulated Gene 1, Leading to Cellular Proliferation and Migration. J Virol. 94(3): e00899-00819. PMID: 31694959 doi: 10.1128/jvi.00899-19
273. Hall, A. L., Kromhout, H., Schuz, J., Peters, S., Portengen, L., Vermeulen, R., . . . Olsson, A. (2020). Laryngeal Cancer Risks in Workers Exposed to Lung Carcinogens: Exposure-Effect Analyses Using a Quantitative Job Exposure Matrix. Epidemiology. 31(1): 145-154. PMID: 31577634 doi: 10.1097/ede.0000000000001120
274. Hariri, S., Sharafi, H., Sheikh, M., Merat, S., Hashemi, F., Azimian, F., . . . Malekzadeh, R. (2020). Continuum of hepatitis C care cascade in prison and following release in the direct-acting antivirals era. Harm Reduct J. 17(1): 80. PMID: 33081794 doi: 10.1186/s12954-020-00431-x
275. Hejazi, J., Ghanavati, M., Hejazi, E., Poustchi, H., Sepanlou, S. G., Khoshnia, M., . . . Hekmatdoost, A. (2020). Habitual dietary intake of flavonoids and all-cause and cause-specific mortality: Golestan cohort study. Nutr J. 19(1): 108. PMID: 32988395 doi: 10.1186/s12937-020-00627-8
276. Hornigold, N., Dunn, K. R., Craven, R. A., Zougman, A., Trainor, S., Shreeve, R., . . . Vasudev, N. S. (2020). Dysregulation at multiple points of the kynurenine pathway is a ubiquitous feature of renal cancer: implications for tumour immune evasion. Br J Cancer. 123(1): 137-147. PMID: 32390008 doi: 10.1038/s41416-020-0874-y
277. Hosen, M. I., Forey, N., Durand, G., Voegele, C., Bilici, S., Avogbe, P. H., . . . Zvereva, M. (2020). Development of Sensitive Droplet Digital PCR Assays for Detecting Urinary TERT Promoter Mutations as Non-Invasive Biomarkers for Detection of Urothelial Cancer. Cancers (Basel). 12(12): 3541. PMID: 33260905 doi: 10.3390/cancers12123541
278. Hosen, M. I., Sheikh, M., Zvereva, M., Scelo, G., Forey, N., Durand, G., . . . Calvez-Kelm, F. L. (2020). Urinary TERT promoter mutations are detectable up to 10 years prior to clinical diagnosis of bladder cancer: Evidence from the Golestan Cohort Study. EBioMedicine. 53: 102643. PMID: 32081602 doi: 10.1016/j.ebiom.2020.102643
279. Howe, L. J., Hemani, G., Lesseur, C., Gaborieau, V., Ludwig, K. U., Mangold, E., . . . Lewis, S. J. (2020). Evaluating shared genetic influences on nonsyndromic cleft lip/palate and oropharyngeal neoplasms. Genet Epidemiol. 44(8): 924-933. PMID: 32710482 doi: 10.1002/gepi.22343
280. Huang, J. Y., Larose, T. L., Luu, H. N., Wang, R., Fanidi, A., Alcala, K., . . . Yuan, J. M. (2020). Circulating markers of cellular immune activation in prediagnostic blood sample and lung cancer risk in the Lung Cancer Cohort Consortium (LC3). Int J Cancer. 146(9): 2394-2405. PMID: 31276202 doi: 10.1002/ijc.32555
281. Islami, F., Poustchi, H., Pourshams, A., Khoshnia, M., Gharavi, A., Kamangar, F., . . . Malekzadeh, R. (2020). A prospective study of tea drinking temperature and risk of esophageal squamous cell carcinoma. Int J Cancer. 146(1): 18-25. PMID: 30891750 doi: 10.1002/ijc.32220
282. Ji, X., Mukherjee, S., Landi, M. T., Bosse, Y., Joubert, P., Zhu, D., . . . Amos, C. I. (2020). Protein-altering germline mutations implicate novel genes related to lung cancer development. Nat Commun. 11(1): 2220. PMID: 32393777 doi: 10.1038/s41467-020-15905-6
283. Kachuri, L., Graff, R. E., Smith-Byrne, K., Meyers, T. J., Rashkin, S. R., Ziv, E., . . . Johansson, M. (2020). Pan-cancer analysis demonstrates that integrating polygenic risk scores with modifiable risk factors improves risk prediction. Nat Commun. 11(1): 6084. PMID: 33247094 doi: 10.1038/s41467-020-19600-4
284. Kachuri, L., Johansson, M., Rashkin, S. R., Graff, R. E., Bosse, Y., Manem, V., . . . Hung, R. J. (2020). Immune-mediated genetic pathways resulting in pulmonary function impairment increase lung cancer susceptibility. Nat Commun. 11(1): 27. PMID: 31911640 doi: 10.1038/s41467-019-13855-2
285. Kleinstern, G., Camp, N. J., Berndt, S. I., Birmann, B. M., Nieters, A., Bracci, P. M., . . . Cerhan, J. R. (2020). Lipid Trait Variants and the Risk of Non-Hodgkin Lymphoma Subtypes: A Mendelian Randomization Study. Cancer Epidemiol Biomarkers Prev. 29(5): 1074-1078. PMID: 32108027 doi: 10.1158/1055-9965.EPI-19-0803
286. Kleinstern, G., Yan, H., Hildebrandt, M. A. T., Vijai, J., Berndt, S. I., Ghesquieres, H., . . . Cerhan, J. R. (2020). Inherited variants at 3q13.33 and 3p24.1 are associated with risk of diffuse large B-cell lymphoma and implicate immune pathways. Hum Mol Genet. 29(1): 70-79. PMID: 31600786 doi: 10.1093/hmg/ddz228
287. Knuppel, A., Fensom, G. K., Watts, E. L., Gunter, M. J., Murphy, N., Papier, K., . . . Key, T. J. (2020). Circulating Insulin-like Growth Factor-I Concentrations and Risk of 30 Cancers: Prospective Analyses in UK Biobank. Cancer Res. 80(18): 4014-4021. PMID: 32709735 doi: 10.1158/0008-5472.Can-20-1281
288. Kreimer, A. R., Chaturvedi, A. K., Alemany, L., Anantharaman, D., Bray, F., Carrington, M., . . . Brennan, P. (2020). Summary from an international cancer seminar focused on human papillomavirus (HPV)-positive oropharynx cancer, convened by scientists at IARC and NCI. Oral Oncol. 108: 104736. PMID: 32502860 doi: 10.1016/j.oraloncology.2020.104736
289. Lantuejoul, S., Fernandez-Cuesta, L., Damiola, F., Girard, N., & McLeer, A. (2020). New molecular classification of large cell neuroendocrine carcinoma and small cell lung carcinoma with potential therapeutic impacts. Translational Lung Cancer Research. 9(5): 2233-2244. PMID: 33209646 doi: 10.21037/tlcr-20-269
290. Larose, T. L., Meheus, F., Brennan, P., Johansson, M., & Robbins, H. A. (2020). Assessment of Biomarker Testing for Lung Cancer Screening Eligibility. JAMA Netw Open. 3(3): e200409. PMID: 32134462 doi: 10.1001/jamanetworkopen.2020.0409
291. Lebrett, M. B., Balata, H., Evison, M., Colligan, D., Duerden, R., Elton, P., . . . Crosbie, P. A. J. (2020). Analysis of lung cancer risk model (PLCOM2012 and LLPv2) performance in a community-based lung cancer screening programme. Thorax. 75(8): 661-668. PMID: 32631933 doi: 10.1136/thoraxjnl-2020-214626
292. McCormack, V., McKenzie, F., Foerster, M., Zietsman, A., Galukande, M., Adisa, C., . . . Dos-Santos-Silva, I. (2020). Breast cancer survival and survival gap apportionment in sub-Saharan Africa (ABC-DO): a prospective cohort study. Lancet Glob Health. 8(9): e1203-e1212. PMID: 32827482 doi: 10.1016/S2214-109X(20)30261-8
293. Montealegre-Paez, A. L., Pacheco-Orozco, R., Martinez-Gregorio, H., Vaca-Paniagua, F., Ardila, J., Cayol, F., . . . Perdomo, S. (2020). Liquid biopsy in the diagnosis and monitoring of cancer patients: opportunities and challenges in Latin America. Revista Colombiana de Cancerología. 24(4): 164-177. doi: 10.35509/01239015.44
294. Murphy, N., Knuppel, A., Papadimitriou, N., Martin, R. M., Tsilidis, K. K., Smith-Byrne, K., . . . Gunter, M. J. (2020). Insulin-like growth factor-1, insulin-like growth factor-binding protein-3, and breast cancer risk: observational and Mendelian randomization analyses with approximately 430 000 women. Ann Oncol. 31(5): 641-649. PMID: 32169310 doi: 10.1016/j.annonc.2020.01.066
295. Nalini, M., Shakeri, R., Poustchi, H., Pourshams, A., Etemadi, A., Islami, F., . . . Malekzadeh, R. (2020). Long-term opiate use and risk of cardiovascular mortality: results from the Golestan Cohort Study. Eur J Prev Cardiol. PMID: 33624066 doi: 10.1093/eurjpc/zwaa006
296. Naudin, S., Solans Margalef, M., Saberi Hosnijeh, F., Nieters, A., Kyro, C., Tjonneland, A., . . . Ferrari, P. (2020). Healthy lifestyle and the risk of lymphoma in the European Prospective Investigation into Cancer and Nutrition study. Int J Cancer. 147(6): 1649-1656. PMID: 32176325 doi: 10.1002/ijc.32977
297. Naudin, S., Viallon, V., Hashim, D., Freisling, H., Jenab, M., Weiderpass, E., . . . Ferrari, P. (2020). Healthy lifestyle and the risk of pancreatic cancer in the EPIC study. Eur J Epidemiol. 35(10): 975-986. PMID: 31564045 doi: 10.1007/s10654-019-00559-6
298. Nicholson, A. G., Sauter, J. L., Nowak, A. K., Kindler, H. L., Gill, R. R., Remy-Jardin, M., . . . Galateau-Salle, F. (2020). EURACAN/IASLC Proposals for Updating the Histologic Classification of Pleural Mesothelioma: Towards a More Multidisciplinary Approach. J Thorac Oncol. 15(1): 29-49. PMID: 31546041 doi: 10.1016/j.jtho.2019.08.2506
299. Pacheco-Orozco, R. A., Montealegre-Paez, L., Cayol, F., Martinez-Gregorio, H., Oliver, J., Frecha, C., . . . Perdomo, S. (2020). AR-V7 as a Biomarker for Resistance to Treatment with Abiraterone/Enzalutamide in Three Latin American Countries: A Hypothetical Cost-Saving Analysis. Oncologist. 25(12): e1990-e1995. PMID: 32721059 doi: 10.1634/theoncologist.2020-0043
300. Pasqual, E., Turner, M. C., Gracia-Lavedan, E., Casabonne, D., Benavente, Y., Chef, I. T., . . . de Sanjose, S. (2020). Association of ionizing radiation dose from common medical diagnostic procedures and lymphoma risk in the Epilymph case-control study. PLoS ONE. 15(7): e0235658. PMID: 32649712 doi: 10.1371/journal.pone.0235658
301. Purdue, M. P., Song, L., Scelo, G., Houlston, R. S., Wu, X., Sakoda, L. C., . . . Yu, K. (2020). Pathway Analysis of Renal Cell Carcinoma Genome-Wide Association Studies Identifies Novel Associations. Cancer Epidemiol Biomarkers Prev. 29(10): 2065-2069. PMID: 32732251 doi: 10.1158/1055-9965.EPI-20-0472
302. Rojas-Jimenez, E., Mejia-Gomez, J. C., Diaz-Velasquez, C., Quezada-Urban, R., Martinez Gregorio, H., Vallejo-Lecuona, F., . . . Vaca-Paniagua, F. (2020). Comprehensive Genomic Profile of Heterogeneous Long Follow-Up Triple-Negative Breast Cancer and Its Clinical Characteristics Shows DNA Repair Deficiency Has Better Prognostic. Genes (Basel). 11(11): 21. PMID: 33227964 doi: 10.3390/genes11111367
303. Rosato, V., Negri, E., Bosetti, C., Malats, N., Gomez-Rubio, P., Consortium, P., . . . La Vecchia, C. (2020). Gallbladder disease, cholecystectomy, and pancreatic cancer risk in the International Pancreatic Cancer Case-Control Consortium (PanC4). Eur J Cancer Prev. 29(5): 408-415. PMID: 32740166 doi: 10.1097/cej.0000000000000572
304. Saberi Hosnijeh, F., Kolijn, P. M., Casabonne, D., Nieters, A., Solans, M., Naudin, S., . . . Vermeulen, R. (2020). Mediating effect of soluble B-cell activation immune markers on the association between anthropometric and lifestyle factors and lymphoma development. Sci Rep. 10(1): 13814. PMID: 32796953 doi: 10.1038/s41598-020-70790-9
305. Saraiya, V., Bradshaw, P., Meyer, K., Gammon, M., Slade, G., Brennan, P., . . . Olshan, A. (2020). The association between diet quality and cancer incidence of the head and neck. Cancer Causes Control. 31(2): 193-202. PMID: 31894494 doi: 10.1007/s10552-019-01261-4
306. Sheikh, M., Kamangar, F., & Malekzadeh, R. (2020). Fifty Years of Research and One Conclusion: Opium Causes Cancer. Arch Iran Med. 23(11): 757-760. PMID: 33220692 doi: 10.34172/aim.2020.95
307. Sheikh, M., Masoudi, S., Bakhshandeh, R., Moayyedkazemi, A., Zamani, F., Nikfam, S., . . . Pourshams, A. (2020). Survival features, prognostic factors, and determinants of diagnosis and treatment among Iranian patients with pancreatic cancer, a prospective study. PLoS ONE. 15(12): e0243511. PMID: 33275621 doi: 10.1371/journal.pone.0243511
308. Sheikh, M., Poustchi, H., Pourshams, A., Khoshnia, M., Gharavi, A., Zahedi, M., . . . Malekzadeh, R. (2020). Household Fuel Use and the Risk of Gastrointestinal Cancers: The Golestan Cohort Study. Environ Health Perspect. 128(6): 67002. PMID: 32609005 doi: 10.1289/ehp5907
309. Sheikh, M., Shakeri, R., Poustchi, H., Pourshams, A., Etemadi, A., Islami, F., . . . Malekzadeh, R. (2020). Opium use and subsequent incidence of cancer: results from the Golestan Cohort Study. Lancet Glob Health. 8(5): e649-e660. PMID: 32353313 doi: 10.1016/S2214-109X(20)30059-0
310. Singleton, R. K., Heath, A. K., Clasen, J. L., Scelo, G., Johansson, M., Calvez-Kelm, F. L., . . . Muller, D. C. (2020). Risk Prediction for Renal Cell Carcinoma: Results from the European Prospective Investigation into Cancer and Nutrition (EPIC) Prospective Cohort Study. Cancer Epidemiol Biomarkers Prev. 30(3): 507-512. PMID: 33335022 doi: 10.1158/1055-9965.EPI-20-1438
311. Tagliabue, M., Mena, M., Maffini, F., Gheit, T., Quirós Blasco, B., Holzinger, D., . . . The Hpv-Ahead Study, G. (2020). Role of Human Papillomavirus Infection in Head and Neck Cancer in Italy: The HPV-AHEAD Study. Cancers (Basel). 12(12): 3567. PMID: 33260360 doi: 10.3390/cancers12123567
312. Tang, H., Jiang, L., Stolzenberg-Solomon, R. Z., Arslan, A. A., Beane Freeman, L. E., Bracci, P. M., . . . Wei, P. (2020). Genome-Wide Gene-Diabetes and Gene-Obesity Interaction Scan in 8,255 Cases and 11,900 Controls from PanScan and PanC4 Consortia. Cancer Epidemiol Biomarkers Prev. 29(9): 1784-1791. PMID: 32546605 doi: 10.1158/1055-9965.Epi-20-0275
313. Thomas, C. E., Wang, R., Adams-Haduch, J., Murphy, S. E., Ueland, P. M., Midttun, O., . . . Yuan, J. M. (2020). Urinary Cotinine Is as Good a Biomarker as Serum Cotinine for Cigarette Smoking Exposure and Lung Cancer Risk Prediction. Cancer Epidemiol Biomarkers Prev. 29(1): 127-132. PMID: 31685561 doi: 10.1158/1055-9965.Epi-19-0653
314. Wang, Y., Gorlova, O. Y., Gorlov, I. P., Zhu, M., Dai, J., Albanes, D., . . . Shen, H. (2020). Association Analysis of Driver Gene-Related Genetic Variants Identified Novel Lung Cancer Susceptibility Loci with 20,871 Lung Cancer Cases and 15,971 Controls. Cancer Epidemiol Biomarkers Prev. 29(7): 1423-1429. PMID: 32277007 doi: 10.1158/1055-9965.EPI-19-1085
315. Waterboer, T., Brenner, N., Klussmann, J. P., Brennan, P., Wieland, U., & Robbins, H. A. (2020). Study results and related evidence do not support use of HPV16 L1 DRH1 antibodies as a cancer screening test. EBioMedicine. 62: 103143. PMID: 33249381 doi: 10.1016/j.ebiom.2020.103143
316. Yang, J. J., Yu, D., Xiang, Y. B., Blot, W., White, E., Robien, K., . . . Shu, X. O. (2020). Association of Dietary Fiber and Yogurt Consumption With Lung Cancer Risk: A Pooled Analysis. JAMA Oncol. 6(2): e194107. PMID: 31647500 doi: 10.1001/jamaoncol.2019.4107
317. Yang, T., Tang, H., Risch, H. A., Olson, S. H., Peterson, G., Bracci, P. M., . . . Wei, P. (2020). Incorporating multiple sets of eQTL weights into gene-by-environment interaction analysis identifies novel susceptibility loci for pancreatic cancer. Genet Epidemiol. 44(8): 880-892. PMID: 32779232 doi: 10.1002/gepi.22348
318. Yu, E. Y. W., Wesselius, A., Mehrkanoon, S., Brinkman, M., van den Brandt, P., White, E., . . . Zeegers, M. P. (2020). Grain and dietary fiber intake and bladder cancer risk: a pooled analysis of prospective cohort studies. Am J Clin Nutr. 112(5): 1252-1266. PMID: 32778880 doi: 10.1093/ajcn/nqaa215
319. Yuan, F., Hung, R. J., Walsh, N., Zhang, H., Platz, E. A., Wheeler, W., . . . Stolzenberg-Solomon, R. (2020). Genome-Wide Association Study Data Reveal Genetic Susceptibility to Chronic Inflammatory Intestinal Diseases and Pancreatic Ductal Adenocarcinoma Risk. Cancer Res. 80(18): 4004-4013. PMID: 32641412 doi: 10.1158/0008-5472.Can-20-0447
320. Zhang, Y. D., Hurson, A. N., Zhang, H., Choudhury, P. P., Easton, D. F., Milne, R. L., . . . Garcia-Closas, M. (2020). Assessment of polygenic architecture and risk prediction based on common variants across fourteen cancers. Nat Commun. 11(1): 3353. PMID: 32620889 doi: 10.1038/s41467-020-16483-3
321. Zhong, J., Jermusyk, A., Wu, L., Hoskins, J. W., Collins, I., Mocci, E., . . . Amundadottir, L. T. (2020). A Transcriptome-Wide Association Study Identifies Novel Candidate Susceptibility Genes for Pancreatic Cancer. J Natl Cancer Inst. 112(10): 1003-1012. PMID: 31917448 doi: 10.1093/jnci/djz246
322. Zhu, J., Shu, X., Guo, X., Liu, D., Bao, J., Milne, R. L., . . . Wu, L. (2020). Associations between Genetically Predicted Blood Protein Biomarkers and Pancreatic Cancer Risk. Cancer Epidemiol Biomarkers Prev. 29(7): 1501-1508. PMID: 32439797 doi: 10.1158/1055-9965.EPI-20-0091
323. Zvereva, M., Pisarev, E., Hosen, I., Kisil, O., Matskeplishvili, S., Kubareva, E., . . . Calvez-Kelm, F. L. (2020). Activating Telomerase TERT Promoter Mutations and Their Application for the Detection of Bladder Cancer. Int J Mol Sci. 21(17): 18. PMID: 32839402 doi: 10.3390/ijms21176034
324. Zvereva, M., Roberti, G., Durand, G., Voegele, C., Nguyen, M. D., Delhomme, T. M., . . . Le Calvez-Kelm, F. (2020). Circulating tumour-derived KRAS mutations in pancreatic cancer cases are predominantly carried by very short fragments of cell-free DNA. EBioMedicine. 55: 102462. PMID: 32249202 doi: 10.1016/j.ebiom.2019.09.042